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ABSTRACT

EVALUATION OF AN ENHANCED MAGNETO-CHEMICAL PROCESS FOR THE
REMOVAL OF PATHOGENS IN WASTEWATER
by
Christine N. Wright
University of New Hampshire, May, 2008
New wastewater treatment technologies are a necessity as a result
of increasingly stringent discharge standards, particularly concerning
viruses. The traditional approach to wastewater treatment consists of
biological treatment, such as trickling filters, biofilms, and activated
sludge. Although these biological processes have been an adequate
means of wastewater treatment, they are intrinsically limited by their
biological nature. A magneto-chemical process, known as CoMag™, has
been developed to improve coagulation and solids separation and expand
upon conventional wastewater treatment techniques.
The research objective of this project was to develop and evaluate
a bench-scale model of the CoMag™ process for the removal of MS2,
poliovirus type 1, rotavirus strain Wa, and adenovirus type 2 from
secondary effluent wastewater, at 24°C and 4°C.

Additionally, the

removal of MS2 was assessed using a 100 gpm CoMag™ pilot plant. The
xiv

results indicate that there was a statistically significant difference (when
a=0.050) in the removal of MS2, when magnetite is added, versus when
magnetite is not added.

In addition, results suggest that MS2 was

removed more effectively using the bench-scale model then the 100 gpm
pilot plant. Employing the bench scale model, the mean Log Reduction
Value for MS2, poliovirus type 1, rotavirus strain Wa and adenovirus type 2
was 2.9182, 3.3893, 3.5313, and 3.482 respectively. Moreover, there was
no statistically significant difference in the removal of MS2, rotavirus strain
Wa, and adenovirus type 2 at 24° and 4°C.

There was, however, a

statistically significant difference in the removal or poliovirus type 1 at 24°
and 4°C.
This research demonstrates that the CoMag™ process has the
ability to achieve > 2 log removal of MS2 and >3 log removal of poliovirus
type 1, rotavirus strain Wa and adenovirus type 2.

Therefore, the

CoMag™ process' has the potential to aid wastewater and water
treatment facilities meet their more stringent water quality permits.

XV

INTRODUCTION

Enteric viruses that can be transmitted from environmental sources
to humans are present in excess of 150 serotypes (Fong and Lipp, 2005).
Viruses are negatively charged particles and are readily adsorb to
particle surfaces. The adsorption of viruses to a surface is affected by the
viral capsid proteins and more importantly the viral surface charge.
Factors which influence viral adsorption are pH, ionic strength, electrolytes
and interfering substances present in the water such as organics and
heavy metals (Bitton et al., 1976).
Wastewater disinfection strategies are designed on the basis of
bacterial removal and do not necessarily protect the public against viral
infection. Viruses are not generally removed as successfully as bacteria by
conventional disinfection processes. In water, the reduction of viral
particles fundamentally depends on two processes: inactivation and
adhesion-aggregation

(Gassilloud

and

Gantzer,

2005). The

use

of

disinfectants to inactivate microorganisms in public water supplies is
credited as one of the greatest public health advancements of the 20 th
century.
Chlorination is the most widely used method of disinfection in the

l

United States and has been vital in minimizing the occurrence of microbial
waterbome disease. However, chlorine can combine with contaminants
naturally present in source waters, such as organic matter, to produce
harmful disinfection by-products (DBPs). DBPs are toxic to aquatic life,
even in small quantities, and are linked with a variety of adverse human
health

effects

ranging

from

(Nieuwenhuijsen et al., 2000).

reproductive

disorders

to

cancer

Furthermore, chlorine disinfection, using

practical doses and contact time, does not eliminate waterbome
protozoan pathogens, such as Cryptosporidium and Giardia (Sobsey,
1989). Alternative disinfection processes, ozone and ultraviolet light, are
somewhat successful at destroying these pathogens. However, the
processes do not always efficiently inactivate pathogenic viruses,
because inactivation efficiency is dependant upon the viral species and
turbidity level (Clancy et al., 2000) ( Sano et al., 2004). Moreover, new
water treatment technologies are needed because discharge standards
concerning DBPs and disinfectants, are becoming increasingly stringent
(USEPA, 2006a).

2

MS2

Coliphages are bacterial viruses that infect and replicate in
Escherichia coli (E. coli). They are ubiquitous inhabitants of the intestinal
tract of humans and animals and are encountered wherever fecal
contamination occurs (Stetler et al., 1984). One type of coliphage that is
commonly assayed for is MS2, a male specific coliphage from the family
Leviviridae. MS2 is a coliphage that is often used as a model or surrogate
to evaluate the presence of human viruses in water quality assessment,
because it resembles enteric viruses more closely then the commonly
used bacterial indicators of fecal pollution, such as coliforms

and

enterococci

and

(Goyal and

Gerba,

1983)(Grabow,

1996) (Vaughn

Metcalf, 1975). The MS2 virion is icosahedral in shape and consists of a
protein coat containing a linear, single-stranded, RNA genome.

MS2

infects male E. coli cells via attachment to the F-pilus. After attachment,
the phage genome enters the cell where it replicates exponentially,
resulting in lysis of the bacterial cell (Cole et al., 2003).
The size, structure, and survival rate of MS2 in the environment is
similar to those of enteric viruses (Grabow, 1986). Laboratory experiments
with individual coliphages have confirmed that many are more resistant
to

environmental

stresses

and

survive

3

longer

in

natural

aquatic

environments than enteric viruses (Kott, 1984).

Furthermore, these

coliphages are at least as resistant, if not more resistant, to commonlyused disinfectants, such as chlorine. In addition, MS2 is removed, from
water, at comparable rates as enteric viruses, during treatment processes.
Thus, male-specific RNA coliphages are useful surrogates for human
enteric viruses in waters.

Poliovirus

Poliovirus is a small, 20 to 30 nm, single-stranded RNA virus belonging
to the Picornaviridae family. It consists of non-enveloped particles which
are comprised of a protein shell surrounding naked RNA genome. The
poliovirus capsid is composed of 60 copies of 4 viral proteins (VP1, VP2,
VP3, and VP4), which are arranged in an icosahedral symmetry. The
surface of poliovirus has a corrugated topography with a prominent, starshaped plateau at the 5-fold axis of symmetry, surrounded by a d e e p
depression and a protrusion at the 3-fold axis (Belnap et al., 2000). The
poliovirus genome is a single-stranded, positive-sense RNA approximately
7,440 nucleotides in length (Fields and Knipe, 1990). The plus-strand,
genomic RNA functions as mRNA for viral protein expression and serves as
a template for negative-strand RNA synthesis (Zhang and Racaniello,

4

1997).
There are three types of poliovirus: 1, 2, and 3. Type 1 is the most
virulent and the most common strain and type 3 is the second most
common strain (Fields and Knipe 1990). Transmission of wild poliovirus
ceased in the United States by 1979 (Strebel et al., 1992). Furthermore, as
a result of an ongoing global vaccination campaign, type 2 poliovirus has
not been detected anywhere in the world since 1999, (CDC, 2001). Both
the Salk and Sabin poliovirus vaccines are trivalent vaccines, meaning
that they are active against all three virus types.
Humans are the only known reservoir of poliovirus, which is
transmitted most frequently by persons with unapparent infections.
Human-to-human transfer of poliovirus, via the fecal-oral route, is the most
commonly implicated mode of transmission, although the oral-oral route
may account for a small number of cases (Horstmann, 1967). Poliovirus
enters through the mouth and primary multiplication occurs at the site of
implantation in the pharynx or gastrointestinal tract. The virus is usually
present in the throat and the gastrointestinal tract for a period of time
before symptoms occur. The virus invades local lymphoid tissue, enters the
blood stream, and then may infect cells of the central nervous system.
Replication of poliovirus in motor neurons of the anterior horn and brain
stem results in cell destruction and causes the typical manifestations of

5

poliomyelitis (Fields and Knipe, 1990). One week after onset, there is little
virus residing in the throat, but virus remains in the gastrointestinal tract
and continues to be excreted in the stool for several weeks.
The response to poliovirus infection is highly variable and has been
categorized based on the severity of clinical presentation; as many as
95% of all polio virus infections are unapparent or asymptomatic. Infected
persons without symptoms shed virus in the stool, possibly transmitting the
virus to others. Approximately 4% to 8% of polio infections consist of a
minor, nonspecific illness without clinical or laboratory evidence of central
nervous system invasion. This clinical presentation is known as abortive
poliomyelitis, and is characterized by complete recovery in two to three
days. Three clinical manifestations associated with abortive poliomyelitis
are upper respiratory tract infection, gastrointestinal disturbances, and
influenza like illness. A complication of poliovirus infections, non-paralytic
aseptic meningitis occurs in l%-2% of infected individuals. Typically
symptoms from aseptic meningitis will last from 2 to 10 days, followed by
complete recovery.
paralysis.

Less than 1% of all polio infections result in flaccid

Paralytic symptoms generally appear 1 to 10 days after

prodromal symptoms and progress for 2 to 3 days (Ryan, 1994).

6

Rotavirus

Rotavirus is a member of the Reoviridae family. Rotaviruses are nonenveloped, double-shelled, triple layered viruses. The nucleocapsid is
isometric, with a non-occluded regular surface shape. Complete particles
measure approximately 70 nm in diameter and have a distinctive doublelayered icosahedral smooth protein capsid that consists of an outer and
an inner layer, when viewed by transmission electron microscopy (Fields
and Knipe 1990). Within the inner capsid is a third layer, the core, which
contains the virus genome consisting of 11 segments of double-stranded
(ds) RNA (Ciarlet et al., 1998). The rotavirus genus is divided into seven
antigenically distinct groups (A to G). Humans are susceptible to infection
from Groups A, B, and C and animals are vulnerable to all groups. Four
group A serotypes, (1, 2, 3 and 4), are of the greatest epidemiological
importance because it is the leading cause of diarrhea in infants and the
elderly (Estes and Cohen, 1989). Infection is primarily restricted to the villus
epithelium of the small intestine, and the outcome of infection is a g e
restricted (Fields and Knipe, 1990).
Human rotavirus is considered the single most important cause of
severe, potentially life-threatening, viral gastroenteritis and dehydrating
diarrhea in young children worldwide.

7

Each year, rotavirus causes

approximately 111 million episodes of gastroenteritis resulting in the need
of home care, 25 million requiring clinic visits, and 2 million resulting in
hospitalizations (Parashar et al., 2003).

Worldwide, over 600,000 child

deaths occur due to dehydration and electrolyte imbalance caused by
rotavirus infection (Ciarlet et al., 2002).

By age 5, nearly every child

experiences an episode of rotavirus gastroenteritis; 1 in 5 will visit a clinic, 1
in 65 will be hospitalized, and approximately 1 in 293 will die as result of
complications from the infection. Children in underdeveloped countries
account for 82% of rotavirus deaths (Parashar et al., 2003).
The primary mode of transmission is the fecal-oral route; low titers of
virus have been cultivated in respiratory tract secretions and other body
fluids (Parashar et al., 2003). On a larger scale, rotaviruses have been
documented as causative agents of waterbome disease outbreaks in the
United States (Gerba, 2000). Waterborne disease outbreaks of rotavirus
gastroenteritis can be attributed to their low infectious dose (1-10
infectious units), ability to survive for extended periods of time in the
environment (only 10% inactivation after 14 days at 23°C), and poor
removal (21% to 27%) by some water treatment processes (GratacapCavallieretal., 2000) .
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Adenovirus

The Adenoviruses belong to the family Adenoviridae. They have an
icosahedral structure and are of medium-size (90-100 nm). The particles
are non-enveloped and the capsid is composed of 252 capsomeres, of
which 240 are hexons and 12 are pentons (Fields and Knipe 1990). Each
penton contains a base, which forms part of the surface of the capsid,
and a projecting fiber, the length of which varies among the different
serotypes (Norrby et al., 1976). The genome is 30,000-42,000 nucleotides
long (Fields and Knipe, 1990). It is comprised of linear, monopartite,
double-stranded DNA and is the only known waterbome human, doublestranded, DNA virus.
Adenoviruses were first discovered in 1953 in tonsil and adenoidal
surgical specimens retrieved from children (Rowe et al., 1956). Similar viral
agents were isolated from military personnel exhibiting a variety of
respiratory illnesses (Hilleman and Werner, 1954). It was soon discovered
that the viruses were antigenically related.
classified

as

adenoid

degeneration

Adenoviruses were first

viruses,

adenoid-pharyngeal

conjunctival viruses and acute respiratory disease viruses. Adenovirus was
a d o p t e d as the family name in 1956 (Liu, 1991).

Over 100 distinct

serotypes are known to exist worldwide in humans, as well as in a variety
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of animals. Fifty-one adenoviruses are currently recognized, which are
classified into 6 subgenera (A through F) based on biochemical,
immunological, and genetic parameters (Leclerc et al., 2002).
Adenoviruses have been identified as a cause of waterborne
illnesses in the United States as well as other countries (Leclerc et al., 2002),
and several serotypes such as 1, 2, 5, and 6, are endemic in many parts of
the world

(Fields and

Knipe, 1990). Although the

epidemiologic

characteristics of the adenoviruses vary by serotype, all are transmitted
via direct contact, fecal-oral transmission, and occasionally waterborne
transmission (Kukkula et al., 1997). Several serotypes are capable of
establishing persistent asymptomatic infections in tonsils, adenoids, and
intestines of infected hosts, and shedding can occur for a period of
months to years (Fields and Knipe, 1990). Adenoviruses are typically stable
when presented with chemical or physical agents and adverse pH
conditions, allowing for prolonged survival outside of the body (ThurstonEnriquez et al., 2003). As a result, adenoviruses are a substantial concern
to public health and have been placed on the U.S. Environmental
Protection Agency Contaminant Candidate List for drinking water (USEPA,
1998).

10

Disinfection

Disinfection is the primary mechanism for the inactivation and
destruction of pathogenic organisms in water and wastewater. (USEPA,
1999b). The goal is to prevent the spread of waterbome diseases to
downstream users and the environment. Achieving this goal successfully
requires choosing the appropriate disinfection process for a particular
water or wastewater treatment facility, which is contingent on many
factors.

The disinfectant must be able to adequately disperse in or

penetrate the water and destroy target organisms. Next, the disinfectant
must be safe and simple to administer in quantities appropriate for the
population density of the vicinity.

Equally as important, use of the

disinfectant must not result in toxic residuals or generation of carcinogenic
or mutagenic byproducts.

Lastly, the disinfection process must be

relatively affordable to operate and maintain. The three most common
types of disinfectants utilized in water and wastewater treatment facilities
are chlorine, ozone and ultraviolet (UV) light.

Chlorine Disinfection

Chlorine is the most common disinfectant of wastewater in the
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United States (USEPA, 1999a). It oxidizes cellular membrane material, by
breaking unsaturated bonds, and has a moderate amount of nucleic
acid activity affecting cellular respiration, transport, and DNA synthesis.
Chlorine can be employed in many forms including chlorine gas, solid
hypochlorite salts, and hypochlorite solutions. When chlorine is a d d e d to
water, it undergoes hydrolysis and ionization until equilibrium is achieved
(Bitton, 1980).

Cl2 + H2O <-• HOCI + H+ + CI- (Hydrolysis reaction)
HOCI «-• H+ + OCI- (Ionization reaction)

The distribution of chlorine species is pH dependant. When the pH
of water is less then 6.0, hypochlorous acid (HOCI) predominates. It is 70 to
80 times more potent as a disinfectant than hypochlorite ions, the
principal species when the pH is greater then 9.0 (USEPA, 1999a). Both
forms are

present at

a

pH between

6.0 and

9.0

(Bitton, 1980).

Hypochlorous acid and hypochlorite ions are referred to as free chlorine.
Total chlorine is composed of free chlorine and combined chlorine.
Combined chlorine is formed when free chlorine coalesces with ammonia
and nitrogenous compounds in the water (Haas, 1990).
Chlorine disinfection has several advantages over other types of
disinfection and is therefore used, the most commonly.
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It is a well

established technology which successfully inactivates a wide range of
waterborne pathogens in a more cost-effective manner than ozone or UV
light. Another advantage of using chlorine as a disinfect in drinking water
facilities, is the fact that it leaves a residual in the water, long after initial
dosing, which can be easily quantified and controlled (USEPA, 1999b).
Maintaining a chlorine residual in a drinking water distribution system can
help control biofilm growth and microorganism recontamination.

There

are, however, several disadvantages to using chlorine as a disinfectant,
one being that chlorine is highly corrosive and toxic. In terms of water
quality, high doses of chlorine can adversely affect taste a n d odor. The
most severe disadvantage is the production of disinfection byproducts
(DBPs).

Disinfection byproducts, including trihalomethanes (THM) and

haloacetic acids (HAA), form when organic matter combines with
chlorine.

Numerous toxicological studies have revealed that THMs and

HAAs may be carcinogenic and teratogenic in laboratory animals (USEPA,
2006a).

Ozone Disinfection

Ozone (O3), a powerful oxidant, is produced when oxygen (O2)
dissociates, due to an energy source, into individual oxygen atoms (O)
a n d subsequently collides with an oxygen molecule to form ozone (USEPA,
13

1999b).
O2 + O <-+ O3 (Formation of ozone)

Ozone is extremely unstable and must be produced immediately
prior to use. Most treatment plants generate ozone by imposing a high
voltage alternating current across an electric discharge g a p that contains
an oxygen-bearing gas (USEPA, 199b).

When ozone decomposes in

water, free radicals such as hydrogen peroxy and hydroxyl are formed.
These free radicals have strong oxidizing abilities and play an active role in
the disinfection process. The primary inactivation mechanism of ozone is
oxidation and disruption of glycoproteins and glycolipids on the outer
membrane orcapsid of the pathogen (USEPA, 199b).
Disinfection of water using ozone has several advantages including
short contact time and elevated oxygen concentration.

In addition,

ozone disinfection is more effective than chlorine in inactivating viruses
and bacteria (Finch and Fairbaim, 1991). Some disadvantages of using
ozone as a disinfectant include high financial expense, possible irritation
and

toxicity, and

the formation

of

disinfection

byproducts,

when

combined with inorganic and organic compounds normally found in
water.

These DBPs include aldehydes, carboxylic acids and bromate

(USEPA, 1999b).
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Ultraviolet Light Disinfection

UV disinfection is a physical disinfection process and does not
require the addition of chemicals to water like chlorine and ozone
disinfection. The optimum wavelength of UV light to effectively inactivate
microorganisms ranges between 240 to 280 nm (USEPA, 1999b). UV light is
produced by applying an electrical discharge through mercury vapor. It
inactivates pathogens by the adsorption of radiation, which causes a
photochemical

reaction

involving

nucleic

acid

and

other

internal

components. This often causes viral destruction via dimerization of
pyrimidine molecules, which results in an inability of the cell or virion to
replicate its genetic material.
UV light disinfection has numerous advantages including efficient
inactivation of bacteria, viruses, and protozoans (USEPA, 1999b).

In

addition, UV disinfection is a physical process rather than a chemical
process,

which

eliminates

transportation,

storage

and

hazardous

management requirements, which are present with ozone and chlorine
disinfection. Finally, UV light does not leave a residual nor does it produce
DBPs.

Disadvantages of UV light disinfection are as follows: high capital

and maintenance costs when compared to chlorine disinfection and
occasional repair and reversal of the destructive effects of UV light by
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microorganisms

through

a

repair

mechanism

known

as

photo

reactivation, or in the absence of light, dark repair (USEPA, 1999b).
UV radiation quickly dissipates in water by either absorption or
reflection, therefore no residual is produced.

As a result, no DBPs are

formed; however, a secondary disinfectant is necessary to maintain a
disinfectant residual throughout the water distribution system.

Disinfection Byproducts

Disinfection byproducts (DBPs) are formed when disinfectants, such
as chlorine and ozone, combine with naturally occurring organic and
inorganic substances present in water.

Recent studies link DBPs to

reproductive and developmental abnormalities such as stillbirth (King et
al., 2000), spontaneous abortion (Waller et al., 1998), low birth weight
(Dodds et al., 1999) and various birth defects (Yang et al., 2000).
addition, epidemiology and toxicology studies have implicated

In
the

consumption of DBPs in the formation of bladder, rectal, and colon
cancers (USEPA, 2006a).
DBPs are classified into four categories including
residuals, inorganic

byproducts, organic

oxidation

disinfectant

byproducts,

and

halogenated organic byproducts (USEPA, 1999b). In the United States,
over 260 million individuals are exposed to DBPs in drinking water.
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The

Stage 1 Disinfection Byproduct Rule (DBPR) is an amendment to the 1989
Surface Water Treatment Rule (SWTR), enacted by the EPA, in order to limit
the amount of disinfection residual and DBPs in water treatment plant
distribution systems. The Stage 1 DBPR, finalized in December 1998, is the
first phase of risk reduction concerning DBPs. The Stage 1 DBPR applies to
community water systems (CWS) and non-transient non-community water
systems (NTNCWS). CWS are public water systems that serve residents of
communities with at least 15 service connections or 25 residents yearround. A NTNCWS is a water system that serves facilities such as schools or
businesses, utilized by at least 25 of the same people, for more then six
months out of the year (USEPA 1999b).

The Stage 1 DBPR requires a

running annual average of DBP across the entire water treatment system.
The Stage 2 DBPR went into effect on March 6, 2006 as a
supplement of previous regulations to reduce risks of DBPs. The Stage 2
DBPR requires that CWS and NTNCWS perform an evaluation of their
distribution system and identify the locations where DBPs are elevated.
The locations which are d e e m e d high risk will be used as sampling sites for
Stage 2 DBPR monitoring. Maximum contaminant levels (MCLs) for two
groups of DBPs, total trihalomethanes

(TTHM) and haloacetic

acids

(HAA5), are established by the Stage 2 DBPR. The MCL, as regulated by
the Stage 2 DBR, for TTHM and HAA5 are 0.080 mg/L and 0.060 mg/L
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respectively (USEPA, 2006a). Total trihalomethanes and HAA5 are two
commonly occurring classes of DBPs formed due to chlorine disinfection
of water. Because these two classes of DBPs generally occur at higher
levels than other DBPS, they are meant to serve as DBP indicators.
There are many factors that affect the formation of DBPs including
pH, temperature, organic and inorganic material, and bromide ion.
Halogenated DBPs are formed when a strong oxidant, such as chlorine or
ozone, react with organic matter or free bromine. Non-halogenated DBPs
are formed when strong oxidants reacts with inorganics present in water.
The EPA has recognized the effect of DBPs long before laws were
enacted to monitor their presence in public water sources. In 1983, the
EPA recognized

treatment

techniques

which would

reduce

the

production of DBPs. One of the primary methods for reducing DBPs
involves the removal of DBP precursors through improved flocculation and
coagulation processes (Nieuwstad et al., 1988).

Hiah Gradient Magnetic Separation

One method of effectively removing a variety of substances from
water is through high gradient magnetic separation (HGMS). This method
requires the separation of weakly magnetic and non-magnetic particles.
HGMS can be facilitated by the addition of particles with a high magnetic
18

susceptibility

to

form

aggregates

of

diamagnetic

particles.

The

diamagnetic particles can then be removed by a type of magnetic
filtration termed high gradient magnetic separation (HGMS) (Ying et al.,
2000).

High gradient magnetic separation was first introduced as a

mitigation and recovery process for several industrial and environmental
applications (Yiacoumi et al., 1996).

The differences of the magnetic

susceptibility of materials determines their recovery from water or removal
as a waste product.

The principles of HGMS are summarized in the

formula below:

FM= MOVH

Where :

(dH/dx)

FM = magnetic force on a particle in a magnetic field
Ho = magnetic susceptibility
V= volume of the particle
H = background magnetic field
(dH/dx) = magnetic field gradient

The theory for particle separation is to create a high gradient
magnetic field (M) within a background field (H). The background field
interacts with moving electric charges; the forces on ions of opposite
charges occur in opposite directions.

The redirection of the particles

increases the frequency with which ions collide and combine.
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According to the above equation, to increase the force of a
particle (FM) material the background magnetic field may be increased
by using stronger electromagnets, however, the cost for
electromagnets is high.

The magnetic field gradient (dH/dx) can be

increased by incorporating

a field matrix, but the operation

maintenance cost is not economical.
convenient way

powerful

to increase the

and

The least expensive and most

Fm is to increase the

magnetic

susceptibility (|Jo) by adding a hetero-coagulant such as magnetite.
Current uses of HGMS include the removal of phosphate from
water, beneficiation of low grade iron ores, kaolin clay refinement,
desulphurization of coal, filtration of nuclear waste coolant, recovery of
hematite and chromite from water, and removal of algae, yeast, and
bacteria from wastewater (Bitton et al., 1974) (Terashima et al., 1986)
(Parker, 1981)(Ying et al., 1999) (Wang et al., 1994) (Bitton and Mitchell,
1974).
All particles can be divided into three categories on the basis of
their magnetic susceptibility; the ratio of the degree of magnetization to
the applied magnetic field strength.
Ferromagnetic

materials,

susceptibility of one,

which

have

These categories include: 1)
a

high

positive

magnetic

2) Paramagnetic materials, which have a weak

positive magnetic susceptibility of 10 3 to 10 5 and
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3) Diamagnetic

materials, which have a negative magnetic susceptibility of 1 x 105 (Tsouris
and Yiacoumi, 1997).

Examples of ferromagnetic materials are iron,

nickel, gadolinium and magnetite.

These materials have very strong

responses to a magnetic field: they become strongly polarized in the
direction of the magnetic field. More importantly, they retain at least
some of their polarization after the magnetic field is removed.

Once

ferromagnetic materials are polarized they produce a magnetic field of
their own. Since these fields are usually not uniform, particularly near the
ends, ferromagnetic materials are capable of attracting each other and
other weakly magnetic particles.
Paramagnetic materials include sodium, oxygen and platinum.
They are affected, somewhat less strongly than ferromagnetic materials,
and are weakly polarized parallel to a magnetic field. Thus, in a nonuniform magnetic field, they undergo a force towards the higher
magnetic

field region.

However, unlike ferromagnetic

materials,

paramagnetic materials do not produce a magnetite field of their own in
the absence of an externally applied magnetic field.
Diamagnetic materials such as copper, lead, quartz, water,
acetone, and carbon dioxide are very weakly affected by magnetic
fields. They become magnetically polarized in the direction opposite of
the magnetic field. If the magnetic field is not uniform, they follow a force
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away from the higher field region. Diamagnetism results from the effects
of magnetic fields on all of the electrons in the material. Thus, all materials
have a diamagnetic response. However, the other forms of magnetism
are stronger than diamagnetism; therefore the diamagnetism is often
ignored, unless it is the only magnetic effect present.
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Figure 1: Response of paramagnetic and diamagnetic materials to a
magnetic field (H).

Figure 2: Response of ferromagnetic materials to a magnetic field (H).

Figures 1 and 2 adapted from: Physics for Scientists and Engineers by R.A
Serway, and J.W. Jewett.
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Magnetite
Magnetite is a ferromagnetic, cubic mineral with the chemical
formula [Fe3+]lv[Fe2+Fe3+]vl04. The International Union of Pure and Applied
Chemistry (IUPAC) name for magnetite is iron (II, III) oxide and the
common name is ferrous-ferric oxide. Magnetite is the most magnetic of
all the naturally occurring minerals on Earth (Moore, 2007). It is a member
of the inverse spinel structure type of which half the ferric ion is
tetrahedrally coordinated and the remaining portion, as well as the total
ferrous iron, is octahedrally coordinated by cubic closed packed oxygen
ions. Magnetite is iron black and opaque in color. The hardness is a 6 on
the Mohs scale and the specific gravity is 5.20. Magnetite occurs in the
granular or massive form, most commonly as a magmatic segregation in
basic rocks. However, it is also chemically produced (Karapinar, 2003). It
is most abundant naturally in Sweden, Norway, Russia and Canada but
also can be found as an accessory mineral in igneous rocks throughout
the world (Moore, 2001).

Hydrolysis of magnetite produces a highly

hydroxylated surface where a charge is generated by the addition of
acidic or alkaline solution. This process is summarized in the following
reversible equation (Bolto and Spurling, 1991):
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V Fe-OH
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The isoelectric point of magnetite is 7.5 ± 0.5 therefore, under acidic
conditions, the surface of magnetite will carry a net positive charge
attracting negatively charged material. When the pH is raised to alkaline
conditions, the surface of magnetite becomes negatively charged and
any

previously

negatively

charged

material

is repelled. Therefore,

because of the magnetic properties of magnetite, at an acidic

pH, it

functions as an adsorbent for colloids, organic materials, bacteria and
viruses (Anderson et al., 1982).
The first reported application, employing magnetite to concentrate
viruses, was reported by Warren et al. using myxoviruses (Warren et al., 1966).
In later research, Rao et al. utilized magnetite to concentrate enteric viruses in
drinking water (Rao et al., 1981). Further research projects, used magnetite
as an adsorbent to remove a variety of contaminants from wastewater
including: T7 bacteriophage, coliform bacteria, suspended solids a n d
algae (Bitton et al., 1974)(de Latour, 1973) (Bitton et al., 1974). Previous
research has also investigated the effects of magnetite and poliovirus
type 1 in a wastewater matrix (Bitton, 1976). This research, demonstrated
that magnetite was an effective adsorbent for poliovirus type 1, resulting
in up to 99.8% removal.
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CoMaq™

The

traditional

approach

to

wastewater

treatment

biological treatment, such as trickling filters, biofilms, and

includes
activated

sludge, which convert organics in the wastewater into sludge and CO2
(Booker et al., 1990). Although these biological processes have been an
adequate means of wastewater treatment, they are intrinsically limited by
their biological nature, illustrated by the fact that they require expertise to
conduct and maintain due to their sensitive nature and susceptibility to
bactericidal contaminants in wastewater. Consequently, establishing
biological processes is expensive and difficult, compared to applying
conventional, physio-chemical, methods of wastewater treatment such as
flocculation and coagulation techniques.
Although presented as a more feasible option than biological
processes to treat wastewater, physio-chemical processes also have
significant shortcomings. Some disadvantages of conventional physiochemical wastewater treatment methods include the high cost of
chemicals and the formation of large amounts of gelatinous sludge
(Booker et al., 1990).

The CoMag™ process is an enhanced magneto-

chemical process that attempts to solve the limitations of current physiochemical and biological wastewater treatment processes by improving

26

aspects of coagulation and solids separation.

In addition, the CoMag™

process provides a flow rate several times faster then conventional flow rates.
This advantage results in a smaller space requirement necessary for
wastewater treatment to occur.
The CoMag™ technique begins with passing influent wastewater
through a pre-conditioning magnetic matrix, prior to precipitation. This step
creates a locally induced magnetic moment, which is sensed by the colloidal
particles. Colloids will not settle when they are suspended in a liquid. The
electrostatic

charges

aggregating.

on

each

particle

prevent

the

colloids

from

Also, the thermal motion of each particle offsets its

gravitational potential energy (Kolm et al., 1975). When HGMS is applied
to colloidal particles suspended in water, there are many forces acting on
them, including attractive van der Waals forces, repulsive electrostatic
forces, and hydrodynamic forces due to water properties and magnetic
moments between permanent or induced magnetic moments (Tsouris et
al., 1995).

In theory, when the strength of the applied high gradient

magnetic field is greater than the thermal motion of the colloid, the
magnetic force created by the field is large enough to increase the
magnetization of the colloid resulting in greatly enhanced precipitation.
After passing through the preconditioning magnet, aluminum sulfate
and polymer are mixed with wastewater, in a series of tanks, allowing for
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maximum coagulation and flocculation. Coagulation or destabilization of a
colloidal suspension, results in the combination of minute particles by physical
and chemical processes and flocculation causes the formation of a larger
settleable structure by bridging. Aluminum potassium sulfate, alum, provides
the necessary coagulation electrolyte, Al+3, which creates a strong bond
between the magnetite seed and the contaminants. The aluminum
cation in solution is coordinated into six ligand ions, forming a metal ion
hydrolysis complex (de Latour, 1973).

The nature of this complex is

dependant on the environment, especially pH.

Depending on the

nucleation step, floe formation of AI(OH)3 may proceed along two
different pathways; homogeneous and heterogeneous.

Homogeneous

growth occurs in the absence of an initial surface site and proceeds as
small precipitates of AI(OH)3 serve as the nucleation site for growth. In
contrast, heterogeneous growth begins in the presence of a seed (Kuo et
al., 1998). When alum is added to a contaminated solution, the solid
surfaces of the contaminants become coated with aluminum hydrolysis
complexes creating a "fluff" around the contaminant (de Latour, 1973).
Alum may aid in coagulation in two ways (Cohen et al., 1971). First, the
"fluff" formed around each particle can enlarge through the process of
aluminum bridging. Second, the surface charge of the particle is altered
when the aluminum hydrolysis complex is adsorbed to its surface. In all but
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strongly alkaline solutions, the complex is positively charged. Considering
that

most waterborne contaminants

are negatively charged

the

reduction of the surface charge of the contaminants make coagulation
achievable.
A nucleation aid, such as bentonite, is then added to increase floe size
and weight. Studies have revealed that virus adsorption to bentonite and
other clays are significant and increase in the presence of a trivalent
cation, such as aluminum sulfate (Carlson et al., 1968)(Schaub et al.,
1974). Fine magnetite powder is also added at this stage to increase floe
density and allow for floe removal using a magnetic separator. Magnetite
displays a net positive charge in an acidic environment and this enables the
negatively charged viruses to attach to the magnetite surface. The tiny
magnetite particles are enmeshed into the floe and function as magnetic
handles. The flocculated solids settle very rapidly in a small clarifier that
operates at an overflow rate, over 10 times that which is typical for standard
physio-chemical processes. A portion of the solids underflow, approximately
80 percent, is recirculated to the first stage contact basin, while the remaining
portion is removed as sludge.

The clarified effluent passes through a

magnetic separator in a final polishing stage to remove microflocs that
escaped the clarifier. Magnetite is recovered from the sludge in a magnetic
drum separator and recycled to the magnetite feed tank for reuse. The
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sludge is removed from the system and ultimately disposed of with the
remainder of the plant sludge produced during biological treatment.
The primary difference between the CoMag™ process and other
conventional technologies occurs during the removal stage. Since
magnetite creates a denser floe, the flocculated particles settle more
rapidly. For that reason, the clarifier is many times smaller than
conventional clarifiers and settling occurs much quicker. Other major
benefits include the removal of pin floe, with a magnetic separator, and
the magnetite seed can be recovered from the sludge using a magnet
instead of gravity.

Concord MA Wastewater Treatment Facility

The Concord Wastewater Treatment Facility (WWTF) was built in
1986 and treats 1.2 million gallons of wastewater per day, according to
monthly average discharge flow. The effluent discharges to the Concord
River.

Treatment through the Concord WWTF currently consists of

headworks, primary settling, single stage trickling filters run in parallel,
secondary clarification, intermittent sand beds for winter season polishing,
and chlorine disinfection.
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Figure 3: Flow diagram for the Concord, MA Wastewater Treatment
Facility and CoMag ™ wastewater treatment process.

CoMag™ Wastewater Treatment Process
Coagulant

Flocculont

Magnetic

Influent

Disinfection

Concord River

I Election

Concord, MA Wastewater
Treatment Plant Flow Chart

I System

Adapted from: Cambridge Water Technology. 2007.
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Figure 4: The CoMag™ Treatment Process
Flocculant
Nucleation Aid
Magnetitie and Coagulant

Influent
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Final
Effluent

Magnetite
Recovery
Drum

To Sludge
Processing

Adapted From: USEPA (United States Environmental Protection Agency).
2007.
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Research Objectives and Technical Approach

Research Objectives
The research objectives of this project were to develop
evaluate a bench scale model of an enhanced

and

magneto-chemical

water treatment process called CoMag™ for the removals of MS2,
poliovirus type 1, rotavirus stain Wa and adenovirus type 2.

Secondary

effluent obtained from the Concord, MA Wastewater Treatment Plant was
the matrix evaluated for the removals of MS2, poliovirus type 1, rotavirus
strain Wa and adenovirus type 2 using the bench scale model of the
CoMag™ process. Bench scale experiments were conducted at room
temperature (24°C) and at a reduced temperature (4°C) to represent the
temperature conditions encountered in New England.

The 100 g p m

CoMag™ pilot plant was then challenged with MS2 coliphage. The d a t a
that was generated from the bench scale and pilot plant studies was
used to develop a correlation of the removal of MS2 to the removals of
poliovirus type 1, rotavirus strain Wa a n d adenovirus type 2.

Technical Approach
1. Evaluate the removal of MS2 using a bench scale model of the
CoMag™ process.
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The removal of MS2 using a bench scale model of fhe enhanced
magneto-chemical water treatment process was evaluated at
room temperature (24°C) and then at a reduced temperature
(4°C).
2. Evaluate the removal ofpoliovirus type 1 and MS2 using a bench scale
model of the CoMag™ process.
The removal of MS2 and poliovirus type 1 using a bench scale
model

of

the

CoMag™

process

was

evaluated

at

room

temperature (24°C) and then at reduced temperature (4°C). A
one-way unstacked ANOVA was performed to evaluate

the

following null hypotheses: (1) there is no statistically significant
difference between the removals of poliovirus type 1 at 24°C and
4°C (2) there is no statistically significant difference between the
removals MS2 and poliovirus type 1 at 24°C and 4°C. A p value of
O.05 was used as a parameter for statistical significance.
3. Evaluate the removal of rotavirus strain Wa and MS2 using a bench
scale model of the CoMag™ process.
The removal of MS2 and rotavirus strain Wa using a bench scale
model CoMag™ process was evaluated at room temperature
(24°C) and then at a reduced temperature (4°C). A one-way
unstacked ANOVA was performed to evaluate the following null
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hypotheses:

(1)

there

is no

statistically

significant

difference

between the removals of rotavirus strain Wa at 24°C a n d 4°C
(2) there is no statistically significant difference between

the

removals MS2 and rotavirus strain Wa at 24°C and 4°C. A p value of
O.05 was used as a parameter for statistical significance.
4. Evaluate the removal of adenovirus type 2 and MS2 using a bench
scale model of the CoMag™ process.
The removal of MS2 adenovirus type 2 using a bench scale model
of the CoMag™ process was evaluated at room temperature
(24°C) and then at a reduced temperature (4°C). A one-way
unstacked ANOVA was performed to evaluate the following null
hypotheses:

(1)

there

is no

statistically

significant

difference

between the removals of adenovirus type 2 at 24°C and 4° C
(2) there is no statistically significant difference between

the

removals MS2 and adenovirus type 2 at 24°C and 4°C. A p value of
O.05 was used as a parameter for statistical significance.
5. Perform statistical analysis and correlate the removal of MS2 with the
removals ofpoliovirus type 1, rotavirus strain Wa and adenovirus type 2.
Statistical analysis of triplicate trials was performed using Minitab version
15 to evaluate the removals of MS2 in the following experiments: MS2
alone with and without magnetite, MS2 and poliovirus type 1, MS2 and
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rotavirus strain Wa and MS2 and adenovirus type 2 at 24°C and 4°C.
An one-way unstacked ANOVA was performed to evaluate the
following null hypotheses: (1) there is no statistically significant
difference between the removals of MS2 when in the presence of
poliovirus type 1, rotavirus strain Wa or adenovirus type 2 when
compared to the removal of MS2 alone at 24° (2) there is no
statistically significant difference between the removals of MS2
when in the presence of

poliovirus type 1, rotavirus strain Wa or

adenovirus type 2 when compared to the removal of MS2 alone at
4°C.

A p value of <0.05 was used as a parameter for statistical

significance.
6. Challenge the CoMag™ process pilot plant with MS2.
An

existing

full-process

100

gallon

per

minute

commercial

demonstration pilot plant was challenged with MS2 at a final
concentration of 1 x 105 PFU/mL three times.

A two-way ANOVA

was performed to evaluate the following null hypotheses: (1) the
CoMag™ pilot plant does not have a statistically significant effect
on the removal of MS2. A p value of O.05 was used as a parameter
for statistical significance.

7. Compare the results for the removal of MS2 at the CoMag ™ pilot
plant to the removal of Ms2 obtained using the bench scale model
of CoMag™ process.
A one-way unstacked ANOVA was performed to evaluate the
following null hypothesis: (1) there is no statistically significant
difference between the removal of MS2 at the pilot plant and the
removal of MS2 using a bench scale model of the CoMag™ process.
A p value of <0.05 will be used as a parameter for statistical
significance.
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CHAPTER II

MATERIALS AND METHODS

MS2 Propagation and Enumeration

MS2 (ATCC 1597-B1) was prepared and quantified using a modified
double agar overlay method a d a p t e d from protocol established by
DeBartolomeis and Cabelli (DeBartolomeis and Cabelli, 1991). A mutant
strain of E. coli HS (pFamp) R served as the host organism. In addition to
displaying a resistance marker to ampicillin on the F plasmid, the selected
host strain is resistant to somatic coliphages T2 to 17 and OX174,
streptomycin, and naladixic acid, (Cho, 2005).
In order to propagate MS2, the E. coli HS (pFamp) R host was grown,
with

gentle

agitation,

to

log

phase

in Tryptic

Soy

Broth (TSB)

supplemented with 1% streptomycin, 1% ampicillin, and 0.5 % magnesium
chloride at 37°C for approximately three hours. MS2 bacteriophage was
then a d d e d to log phase host culture a n d incubated statically at 37°C for
12 to 18 hours. Subsequent to incubation, the E. coli and MS2 suspension
was centrifuged at 10,000 rpm, at 4°C, for ten minutes. The supernatant
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was removed and filtered using a 0.22 pm filter to remove bacteria and
cellular debris.

The filtrate was then placed in sterile bottles and

refrigerated at 4°C, until use.
As previously mentioned, the MS2 was enumerated using a
modified double-agar overlay technique in which E. coli HS (pFamp) R
acted as the host (DeBartolomeis and Cabelli, 1991). The E. coli host was
grown to log phase in TSB supplemented with 1% streptomycin, 1%
ampicillin, and 0.5 % magnesium chloride at 37°C for approximately three
hours.

Serial dilutions of the sample were prepared using Phosphate

Buffered Saline. Five mL of soft agar overlay was inoculated with 100 ul of
the appropriate dilution and 200 ML ° f 'og phase E. coli.

Each sample

was gently swirled and poured onto a 1.5% Tryptic Soy Agar (TSA) 100 mm
plate supplemented with 1% streptomycin and 1% ampicillin, followed by
an overlay. The plates were inverted and incubated at 37°C for 18 to 24
hours. Each plate was examined for plaques and those containing 30 to
300 plaques were used to calculate the titer of the sample. The final titer
of the sample was recorded as plaque forming units per mL (PFU/mL).

Poliovirus Propagation and Enumeration

Poliovirus type 1 LSc was propagated on Buffalo Green Monkey
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Kidney (BGMK) cells, a continuous African monkey kidney cell line (WHO,
1997). Poliovirus LSc is a variant of the Mahoney strain of Poliovirus. The
Mahoney strain was isolated by T. Francis, in 1941, from a composite of 3
stools collected

from asymptomatic

patients with

poliomyelitis in

Cleveland (Li, 1955).
The BGMK cells were grown in Eagle's Minimal Essential Media
(MEM), supplemented with L-15 and 5% Fetal Bovine Serum (FBS). For
poliovirus propagation, BGMK cells were grown to 90% confluency, in
closed 75 cm 2 cell culture flasks at 37°C, with 15 mL of MEM.

The

confluent monolayers of BGMK cells were inoculated with 100 pL of
poliovirus type 1 and incubated at 37°C for 90 minutes, with rocking every
15 minutes, to facilitate viral adsorption and maintain hydrated cells. One
75 cm 2 cell culture flask was inoculated with 100 |jL of warm serum-free
MEM to act as the negative control.
Following incubation, 15 mL of a maintenance media consisting of
MEM supplemented with L-15 and 2% FBS was added to all flasks and the
cells were incubated at 37°C. The flasks were observed daily for evidence
of cytopathic effects (CPE). Once 90% CPE was observed, flasks were
frozen at -80°C and rapidly thawed at 37°C. This freeze/thaw process was
repeated three times to completely lyse the cells and facilitate viral
release. The cell lysates were then centrifuged at 1000 x g for ten minutes
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to pellet cellular debris. Then the supernate was filtered with a 1 % FBS
pretreated 0.22 |jm PVDF filter. The filter was pretreated to reduce the
adsorption of virus to the filter.

Virus was stored at 4°C for short term

storage a n d -80°C for long term storage.
Enumeration of the virus was performed using a modified neutral
red plaque-forming unit (PFU) method (Dulbecco and Vogt, 1953). BGMK
cells were grown to 90% confluency in closed 25 c m 2 culture flasks,
supplemented with 5% FBS. The cells were washed three times with serumfree MEM. Virus to be analyzed was serially diluted in serum-free MEM and
closed 25 c m 2 culture flasks were inoculated, in triplicate, with 100 |JL of
the appropriate poliovirus dilution. The flasks were then incubated at 37°C
for 90 minutes, with rocking every 15 minutes, to facilitate viral adsorption
and maintain hydrated cells.

Following adsorption 10 mL of medium

consisting of MEM supplemented 2% FBS, 2% flake agar (Difco), and
neutral red (Sigma) was a d d e d .

This overlay provides a solid support

matrix to physically confine the virus as well as a viability stain to observe
plaque formation.
Flasks were then inverted and incubated at 37°C and observed for
plaques every 24 hours, for up to seven days.

Only plates containing 20

to 50 plaques were counted. Plaques were quantified and PFU/mL was
determined.

Enumerated poliovirus stocks were stored at -80°C, until
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needed for bench scale CoMag™ challenges.

Rotavirus Propagation and Enumeration

Rotavirus strain Wa (Tissue Culture adapted) (ATCC, VR-2018)
propagation

and

enumeration was accomplished

protocols established by Smith et al. (Smith, 1979).

using

modified

Rotavirus was

propagated on MA-104 (ATCC, CRL-2378.1), an embryonic Rhesus
monkey kidney cell line.

MA-104 cells were grown in Eagle's MEM

supplemented with L-15 and 10% Fetal Bovine Serum (FBS). For rotavirus
propagation, MA-104 cells were grown to 90% confluency, in closed 75
cm 2 cell culture flasks at 37°C, in 15 mL of MEM, supplemented with L-15
and 10% FBS. Ninety percent confluent monolayers of MA-104 cells were
inoculated with 100 pL of rotavirus strain Wa and incubated at 37°C for 90
minutes, with rocking every 15 minutes, to facilitate viral adsorption and
maintain hydrated cells. One 75 cm 2 cell culture flask was inoculated with
100 pL of warm serum-free MEM to serve as the negative control.
Following incubation, 15 mL of a maintenance media, consisting of
MEM supplemented with L-15 and 2% FBS, was added to all flasks and the
cells were incubated at 37°C. The flasks were observed daily for evidence
of CPE. Once 90% CPE was observed, flasks were frozen at -80°C and
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rapidly thawed at 37°C, three times, to completely lyse the cells and
facilitate viral release. The cell lysates were then centrifuged at 1000 x g
for 10 minutes to pellet cellular debris. The supernatant was filtered with a
1 % FBS pretreated 0.22 pm PVDF filter. Virus was stored at 4°C for short
term storage and at -80°C for long term storage.
Rotavirus strain Wa was enumerated using a modified plaqueforming unit (PFU) method (Smith, 1979). MA-104 cells were grown to 90%
confluency, in closed 25 c m 2 culture flasks, supplemented with 10% FBS.
All cells were washed three times with serum-free MEM.

Virus to be

analyzed was serially diluted in serum-free MEM and closed 25 c m 2 culture
flasks were inoculated, in triplicate, with 100 |JL of the appropriate rotavirus
dilution.
The flasks were then incubated at 37°C, for 90 minutes, with rocking
every 15 minutes to facilitate viral adsorption and maintain hydrated cells.
Following adsorption, 10 mL of medium, consisting of equal portions of 2X
MEM, supplemented with 1 mg/mL of trypsin (Gibco) and 2.4% agar
(Sigma), was a d d e d .
Flasks were then incubated at 37°C for four days.

Following

incubation, 2 mL of 10% formaldehyde, in normal saline solution, was
a d d e d to each flask. The flasks were then returned to the 37°C incubator
overnight.

Upon removal from the incubator, the solid overlays were
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removed from the flasks using warm tap water. Two mL of a 0.1% crystal
violet solution was a d d e d to each flask to permit contrast between live
MA-104 cells and plaques. Plaques were quantified a n d a PFU/mL value
was determined. Enumerated rotavirus stocks were stored at -80°C, until
retrieved for bench scale CoMag™ challenges.

Adenovirus Propagation and Enumeration

Adenovirus

type

2

(ATCC,

VR-846)

was

propagated

and

enumerated in A549 (ATCC, CCL-185), a continuous human lung cell line
as previously described by Wold (Wold, 1999). A549 cells were grown in
Eagle's MEM, supplemented with L-15 and 10% FBS.

For adenovirus

propagation, A549 cells were grown to 90% confluency, in closed 75 c m 2
cell culture flasks at 37°C, in 15 mL of MEM supplemented with L-15 and
10% FBS. Confluent monolayers of A549 cells were inoculated with 100 (jL
of adenovirus type 2 and incubated at 37°C for 90 minutes, with rocking
every 15 minutes, to facilitate viral adsorption and maintain hydrated
cells. One 75 c m 2 cell culture flask was inoculated with 100 |jL of warm
serum-free MEM, which served as the negative control.

Following

incubation,

of

15 mL of

a

maintenance

media, consisting

MEM

supplemented with L-15 and 2% FBS, was a d d e d to all flasks, which were
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incubated at37°C.
The flasks were observed daily for evidence of CPE. Once 90% CPE
was observed, the flasks were frozen at -80°C and rapidly thawed at 37°C,
three times, to completely lyse the cells and facilitate viral release. The
cell lysates were then centrifuged, at 1000 x g for ten minutes, to pellet
cellular debris. The supernatant was filtered with a 1% FBS pretreated 0.22
|jm PVDF filter. Virus was stored at 4°C, for short term storage, and at 80°C for long-term storage.
Adenovirus type 2 was enumerated

using the Tissue Culture

Infective Dose 50 (TCID50) method (Meng, 1996). A549 cells were grown in
96 well cell culture plates, at 37°C and 5% CO2, until 90% confluency was
achieved. Virus to be analyzed was serially diluted in serum-free MEM and
25 JJL of the viral dilution was inoculated into 10 wells, in triplicate.
Negative wells contained 25 |jL of serum-free MEM. The plates were then
incubated, for 90 minutes at 37°C and 5% CO2, followed by an addition of
200 u i MEM, supplemented with L-15 and 2% FBS.

The plates were

incubated at 37°C and 5% CO2 for ten days.
Cells were observed daily for evidence of CPE.

Wells which

exhibited CPE within ten days were recorded as positive a n d wells not
displaying CPE were recorded as negative. The number of positive and
negative wells were then referenced to calculate the TCID50 value, using
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the Reed and Muench method illustrated below (Reed, 1938).
Calculation of TCID50:

Log TCID50/ mL = log [{10 exp [X + (p - 0.5)]} / inoculum
volume]

Where:

X = positive exponent from last dilution where all wells
are positive
p = ratio of positive wells/ total number of wells

Sample Collection

All CoMag™ bench scale experiments were conducted using
secondary effluent from the Concord Wastewater Facility in Concord,
MA. The secondary effluent was sampled after trickling filter treatment of
the wastewater, but before chlorine disinfection. An adequate amount of
secondary effluent was collected, in one visit, to conduct all CoMag™
bench scale challenges and stored at 4°C; this minimized variation of
results a n d allowed for comparison of all data produced by the bench
scale model.

Bench Scale Experiments

All bench scale experiments were performed using a Phipps and
Bird ™ 6- paddle Jartester.
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Figure 5: Phipps and Bird ™ 6- paddle Jartester used for bench top experiments.
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MS2

The removal of MS2, using a bench scale model of the CoMag™
process, without a d d e d magnetite and at room temperature (24°C), was
evaluated. In addition the removal of MS2, using a bench scale model of
the CoMag™ process, was evaluated at room temperature (24°C) and
then at a reduced temperature (4°C). All trials were performed in
triplicate. Initial CoMag™ bench scale trials were performed using MS2.
One thousand milliliters of secondary effluent was placed into five sterile
1200 mL beakers. Two of the beakers functioned as controls, with one of
the controls consisting of secondary effluent with MS2, spiked to a final
concentration of 1 x 105 PFU/mL, with no chemicals a d d e d . The purpose
of this particular control was to reveal any removal or inactivation of MS2
because of rapid stirring with the six-paddle jartester, settling during the
quiescent step, toxins in the wastewater, or other nonspecific methods.
The second control contained only 1000 mL of secondary effluent and the
appropriate chemicals.

The purpose of this control was to reveal the

presence of any anthropogenic viruses in the chemicals or the water
matrix.
Each experiment included three test beakers, consisting of 1000 mL
of secondary effluent and MS2, spiked to a final concentration of 1 x 105

48

PFU/mL

The two controls and three test beakers were stirred, using the

six-paddle jartester.

After the samples were briefly stirred, and prior to

addition of the chemicals, an aliquot was removed from each beaker, to
determine the initial concentration of MS2. The CoMag™ process was
then applied to the samples and after a brief settling time a final aliquot
was removed from each beaker to determine the final MS2 titer. Refer to
Appendix C for the CoMag™ process bench scale procedure.

All

samples were analyzed immediately and the remainders of the samples
were archived at -80°C.
The initial and final concentrations of all samples were established
by creating ten-fold dilutions in phosphate buffered saline.

Dilutions

ranging from 10~2 to 10"5 were assayed to determine the initial titer. For the
final titer, dilutions ranging from 10° to 10"3were assayed. All dilutions were
plated in triplicate.
A negative control consisted of 5 mL of soft agar overlay poured on
a plate.

An additional negative control, containing 5 mL of soft agar

overlay which was previously inoculated with 200 pL of log phase E. coli,
was also plated. A positive control consisted of 200 u l of log phase E. coli
plated in 5 mL of a soft agar overlay. After the overlay solidified, 20 ML of
stock MS2 was distributed onto the plate.
All samples were analyzed using the double agar overlay method,
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as previously described. Plates containing 30 to 300 plaques were used to
calculate the titer of the sample. The titer of the sample was recorded as
plaque forming units per mL (PFU/mL).

Poliovirus type 1 and MS2

The removal of MS2 and poliovirus type 1, using a bench scale
model of the CoMag™ process was evaluated at room temperature
(24°C) and then at a reduced temperature

(4°C). All trials were

performed in triplicate. One thousand milliliters of secondary effluent was
distributed into five sterile 1200 mL beakers. Two of the beakers a c t e d as
controls. One of the controls consisting of secondary effluent and MS2,
spiked to a final concentration of 1 x 105 PFU/mL, and poliovirus type 1,
spiked to a final concentration of 1 x 105 PFU/mL.

The other control

contained 1000 mL of secondary effluent and all of the appropriate
chemicals.

This control

confirmed

the

presence

or

absence

of

anthropogenic viruses. A positive control consisting of 200 u l of log phase
E. coli plated in five mL of a soft agar overlay. After the overlay solidified,
20 (JL of stock MS2 was distributed onto the plate.
Additionally, three test beakers, consisting of 1000 mL of secondary
effluent

were

spiked with

MS2 and
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poliovirus

type

1 to

a

final

concentration of 1 x 105 PFU/mL of each virus. The two controls and three
test beakers were stirred using a six paddle jartester.
After the samples were briefly stirred, and prior to

chemical

addition, an aliquot was removed from each beaker to determine the
initial viral concentration.

The CoMag™ process was applied to the

samples and after a brief settling time a final aliquot was removed to
determine the final titer of MS2 and poliovirus type 1 in each beaker.

All

samples were analyzed immediately and the remainder archived at 80°C.
The initial and final concentrations of the MS2 samples were
determined by using ten-fold dilutions made in phosphate buffered saline.
For the initial concentration of MS2, dilutions ranging from 10"2 to 10"5 were
assayed and dilutions ranging from 10° to 10-3 were assayed to determine
the final concentration of MS2. All dilutions were plated in triplicate.
A negative control consisting of 5 mL of plated soft agar overlay. A
second negative control contained 200 uL of log phase E. coli in 5 mL of a
soft agar overlay. A positive control consisting of 200 u l of log phase E.
coli in five mL of a soft agar overlay. After the overlay solidified, 20 |jL of
stock MS2 was spotted onto the plate.
All samples were analyzed using the double agar overlay method,
as previously described. Plates containing 30 to 300 plaques were used to
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calculate the titer of the sample. The titer of the sample was recorded as
plaque forming units per mL (PFU/mL).
The initial and final concentrations of poliovirus type 1, in all
samples, were determined using ten-fold dilutions prepared in serum-free
MEM. To determine the starting virus concentration, dilutions ranging from
10"2 to 10"5 were assayed and dilutions ranging from 10° to 10"3 were
assayed to determine the final concentration of poliovirus type 1.

All

dilutions were plated in triplicate.
Two negative control flasks contained 100 |JL of serum-free MEM.
Two positive control flasks contained 100 pL of 1 x 102 PFU/mL poliovirus
type 1 stock.

Only flasks containing 20 to 50 plaques were counted.

Plaques were quantified and a PFU/mL value was determined.

Rotavirus strain Wa and MS2

The removal of MS2 and rotavirus strain Wa using a bench scale
model of the CoMag™ process was evaluated at room temperature
(24°C) and at a reduced temperature (4°C). All trials were performed in
triplicate. One thousand milliliters of secondary effluent was placed into
five sterile 1200 mL beakers. Two of the beakers were as controls. One of
the controls consisting of only secondary effluent and MS2 spiked to a final
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concentration of 1 x 105 PFU/mL and rotavirus strain Wa spiked to a final
concentration of 1 x 105 PFU/mL. An additional control contained 1000 mL
of secondary effluent and all of the chemicals required for the CoMag™
process. This control was used to demonstrate the presence or absence
of naturally occurring virus.
Three test beakers consisting of 1000 mL of secondary effluent and
MS2 spiked to a final concentration of 1 x 105 PFU/mL as well as rotavirus
strain Wa, spiked to a final concentration of 1 x 105 PFU/mL. The two
controls and three test beakers were stirred using a six paddle jartester.
After the samples were briefly stirred, and prior to chemical addition, an
aliquot was removed from each beaker to determine the initial
concentration of virus. The CoMag™ process was applied to the samples
and after a brief settling time a final aliquot was removed to determine
the final titer of MS2 and rotavirus strain Wa in each beaker.

All samples

were analyzed immediately and the remainder of each sample was
archived at -80°C.
The initial and final concentrations of MS2 samples were determined
by using ten-fold dilutions prepared in phosphate buffered saline. Dilutions
ranging from 10-2 to 10-5 were assayed to determine initial MS2 titer.
Additionally, dilutions ranging from 10° to 10"3 were assayed to determine
the final MS2 concentration. All dilutions were plated in triplicate.
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A negative control consisted of 5 mL of plated soft agar overlay. A
second negative control contained 200 |JL of log phase E. coli in 5 mL of
soft agar overlay which was then plated. A positive control consisted of
200 |JL of log phase E. coli plated in five mL of a soft agar overlay. After
the overlay solidified, 20 (JL of stock MS2 was spotted onto the plate.
All samples and controls were analyzed using the double agar
overlay method as previously described.

Plates containing 30 to 300

plaques were used to calculate the titer of the sample. The titer of the
sample was recorded as plaque forming units per mL (PFU/mL).
The initial and final concentrations of rotavirus strain Wa, in all
samples, were determined by using ten-fold dilutions prepared in serumfree MEM. To determine the initial titer, dilutions ranging from 10"2 to 10"5
were assayed. Likewise, to determine the final titer, dilutions ranging from
10° to TO"3were analyzed. All dilutions were plated in triplicate.
Two negative control flasks consisted of 100 ML of serum-free MEM.
Two positive control flasks contained 100 pL of 1 x TO2 PFU/mL rotavirus
strain Wa stock. Only flasks containing 20 to 50 plaques were counted.
Plaques were quantified and a PFU/mL value was determined.

Adenovirus type 2 and MS2

The removals of MS2 and adenovirus type 2, using a bench scale
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model of the CoMag™ process was evaluated at room temperature
(24°C) and at a reduced temperature of (4°C). All trials were performed in
triplicate. One thousand milliliters of secondary effluent was placed into
five sterile 1200 mL beakers. Two of the beakers acted as controls. One of
the controls consisted of secondary effluent and MS2, spiked to a final
concentration of 1 x 105 PFU/mL, and adenovirus type 2, spiked to a final
concentration of 1 x 105 TCIDso/mL. The other control contained 1000 mL
of secondary effluent and all of the necessary chemicals. This control was
used to demonstrate the presence or absence of any naturally occurring
virus in the experimental matrix.
Three test beakers, consisted of 1000 mL of secondary effluent and
MS2, spiked at a final concentration of 1 x 105 PFU/mL as well as
adenovirus type 2, spiked at a final concentration of 1 x 105 TCIDso/mL.
The two controls and three test beakers were then stirred using a six
paddle jartester.

After the samples were briefly stirred, and prior to

chemical addition, an aliquot was removed from each beaker to
determine the initial concentration of virus. The CoMag™ process was
then applied to the samples and, after a brief settling time, a final aliquot
was removed to determine the final titer of MS2 and adenovirus type 2 in
each beaker. All samples were analyzed immediately and the remainder
of each sample was archived at -80°C.
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The initial and final concentrations of the MS2 samples were
determined by creating ten-fold dilutions using phosphate buffered saline.
For the initial titer, dilutions ranging from 10-2 to 10 5 were assayed;
additionally, dilutions ranging from 10° to 10"3 were assayed to determine
the final MS2 concentration. All dilutions were plated in triplicate.
A negative control consisted of 5 mL of plated soft agar overlay. A
second negative control contained 200 pL of log phase E. coll in 5 mL of a
soft agar overlay which was plated. A positive control consisted of 200 |JL
of log phase E. coll plated in five mL of a soft agar overlay. After the
overlay solidified, 20 |jL of stock MS2 was spotted onto the plate.
All samples were analyzed using the double agar overlay method,
as previously described. Plates containing 30 to 300 plaques were used to
calculate the titer of the sample. The titer of the sample was recorded as
plaque forming units per mL (PFU/mL).
The initial and final concentrations of adenovirus type 2, in all
samples, were determined by creating ten-fold dilutions in serum-free
MEM. To determine the initial titer, dilutions ranging from 10-2 to 10~5 were
assayed. Likewise, to determine the final titer, dilutions ranging from 10° to
10"3were analyzed. All dilutions were plated in triplicate.
Two negative control wells contained 125 JJL of serum-free MEM.
Two positive control wells contained 125 pL of 1 x 102 TCIDso/nnL adenovirus
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type 2 stock.

Samples were assayed according to methods previously

described.
Adenovirus type 2 viral concentration was reported as TCID50 and
MS2 titers are reported as PFU/mL.

Due to the difference in the

calculation of titers, a conversion from TCID50 to PFU/ mL is necessary in
order to make a comparison possible. The mean TCID50 titer (per ml) was
multiplied by 0.7 to predict the mean number of PFU/mL (Wijnker et al.,
2007).

Pilot Plant Scale Experiments

Preparation of MS2 Spike

A high-titer stock of MS2 was cultivated and enumerated using the
double agar overlay method, as previously described. The MS2 stock was
then diluted in 15 L of sterile deionized water, in a 5 gallon container,
resulting in a final dilution of 1 xlO 8 PFU/mL.

Pilot Plant at the Concord. MA Wastewater Treatment Facility

The CoMag ™ pilot plant is located inside the Concord, MA WWTF.
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A pilot plant flow of 100 gallons per minute (gpm) was determined to be
consistent with the optimum flow rate established during previous
phosphorus studies. Addition of the spiked MS2 sample occurred in the
first rapid mix tank and was continuously metered using a positive
displacement pump. The target concentration of MS2 was 1 x 105 PFU/mL
Aluminum sulfate and polymer were then mixed in a series of tanks for
coagulation and flocculation. Fine magnetite powder was also added at this
stage to increase floe density and allow for floe removal using a magnetic
separator. The flocculated solids settled very rapidly in the small clarifier.
Approximately 80 percent of the solids underflow was recirculated to
the first stage contact basin and the remaining portion was removed as waste
sludge. The clarified effluent was passed through a magnetic separator in
order to remove microflocs that escaped the clarifier. The detention time of
the system was 10 minutes. Magnetite was recovered from the sludge in a
magnetic drum separator and recycled to the magnetite feed tank for reuse.
One hundred mL samples were drawn from the 5 gallon container used
for spiking, as well as the tank where the MS2 was added and a port
located distal to the magnetic separator.
Samples were gathered at time zero and then once every 10 minutes
for a total of three hours. The samples were stored on ice and analyzed within
24 hours.

MS2 was enumerated using the double agar overlay, as
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previously described. Plates containing 30 to 300 plaques were used to
calculate the titer of the sample.

The final titer of the sample was

recorded as plaque forming units per mL (PFU/mL).

Statistical Analysis

The log reduction value (LRV) for MS2, poliovirus t y p e l , rotavirus
strain Wa, and adenovirus type 2 was calculated by dividing the final viral
concentration (Nt) by the initial viral concentration (No). These values
were then logio transformed [logio (N/No)] and the values from the
triplicate experiments were averaged.

The value was

considered

significant at a 95% confidence level. Minitab version 15 was utilized to
perform the statistical analysis.
Statistical analysis of triplicate trials were performed to evaluate the
removals of MS2 with and without magnetite, MS2 alone, MS2 and poliovirus
type 1, MS2 and rotavirus strain Wa, and MS2 and adenovirus type 2 at 24°C
and 4°C. The data for all four viruses were square root transformed to
insure a normal distribution and then analyzed using a one-way ANOVA
with Minitab v. 15.

An ANOVA was performed to evaluate the following

null hypotheses: (1) the bench scale model of the CoMag™ process does
not have a statistically significant effect on the removal of MS2, poliovirus
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type 1, rotavirus strain Wa, and adenovirus type 2 at 24°C or at 4°C; (2) there
is not a statistically significant difference between the removal of MS2with
poliovirus type 1, rotavirus strain Wa, and adenovirus type 2, compared to the
removal of MS2 alone; (3) there is not a statistically significant difference
between the removal of MS2 alone, MS2 with poliovirus type 1, MS2 with
rotavirus strain Wa, and MS2 with adenovirus type 2 at 24°C, compared to
their removal at 4°C; (4) the pilot plant scale of the CoMag™ process
does not have a statistically significant effect on the removal of MS2; (5)
there is no statistically significant difference between the removal of MS2,
using the pilot plant scale CoMag™ process and the bench scale model of
the CoMag™ process; (6) there is no statistically significant difference
between the removals of MS2 using the bench sale model of the CoMag™
process when magnetite is added and when magnetite is not added. A p
value of O.05 was chosen to determine statistical significance.
Post hoc comparisons using the Tukey honest significant difference
(HSD) analysis were performed. The test was performed using a P value of
P < 0.05 to be considered statistically significant. The Tukey HSD Test was
implemented using the means of the MS2 titers for all of the experiments
to create a

pair-wise comparison of each experiment.

This test

determined the presence of a statistically significant difference in the
removal of MS2 among trials.
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CHAPTER III

RESULTS

Removal of MS2 with and without Added Magnetite

The removal of MS2, using a bench scale model of the CoMag™
process, with and without added magnetite, was evaluated. All trials were
performed in triplicate.

The log reduction value (LRV) for MS2 was

calculated by dividing the final viral concentration (Nt) by the initial viral
concentration (No). These values were then logio transformed [logio
(N/No)], and the values from the triplicate experiments were averaged.
The calculated values were considered statistically significant at a 95%
confidence level. Minitab version 15 was utilized to complete the
statistical analysis. The results of the three trials are summarized in Tables 1
and 2 and Figures 6 and 7.
The amount of endogenous MS2, present in the sample matrix, was
below the detectable limit of <1 PFU/mL.

The average LRV for the

removal of MS2 using the CoMag™ process without the addition of
magnetite, was 1.8040 with a standard deviation of 0.3280. The average
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LRV for the removal of MS2 using the CoMag™ process with the addition
of magnetite was 2.9638 with a standard deviation of 0.1217. Statistical
analysis resulted in a p value of 0.005, indicating that there is a significant
difference in the removal of MS2, when magnetite is added, versus when
magnetite is not added.

Therefore, the null hypothesis stating that

magnetite does not have a statistically significant effect on the removal
of MS2 was rejected.
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Figure 6: The removal of MS2, using a Bench Scale model of the CoMag™
process, with and without a d d e d magnetite.
A

Magnetite added

B

No magnetite added

Magnetite added

c

Magnetite added

No magnetite added

D

No magnetite added

Magnetite added

No magnetite added

One thousand milliliters of secondary effluent from the Concord, MA
Wastewater Treatment Facility was placed into sterile 1200 mL beakers. All
chemicals used for CoMag™ process, except for magnetite to the beaker
on the right of each photo, were a d d e d to both beakers. Elapsed time
after chemical addition: (A) 30 seconds (B) 1 minute (3) 30 minutes and
(D) 1 hour.
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Table 1: One-way ANOVA: Mean MS2 LRV: No Magnetite vs. Magnetite
Source
Factor
Error
Total

SS
2.0172
0.2453
2.2624

DF
1
4
5

MS
2.0172
0.0613

F
P
32.90 0.005

S = 0.2476 R-Sq = 89.16% R-Sq(adj) = 86.45%

Individual 95% CIs For Mean Based on
Pooled StDev
Level
No Magnetite
Magnetite

N
3
3

Mean
1.8041
2.9638

StDev
0.3284
0.1217
1.50

—+
2.00

+_
2.50

3.00

Pooled StDev = 0.2476

Table 2: Descriptive Statistics: Mean MS2 LRV: No Magnetite vs. Magnetite

Variable
Count
No Magnetite
3
Magnetite
3

Total
Mean
1.8040
2.9638

Sum of
StDev Squares
0.3280
9.9800
0.1217 26.3816

Minimum Median
1.4320
1.9260
2.8305
2.9917

Maximum
2.0540
3.0691

Data in Tables 1 and 2 represents the calculated LRV of MS2, using data
from three separate trials. For each trail, the removal of MS2 was assayed
in triplicate. The plaque assays were also conducted in triplicate.
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Figure 7: Mean Log Reduction Value of MS2 Using the Bench Scale Model
of the CoMag™ Process
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The data represents the average LRV for MS2, detected by modified
double agar overlay, using E. coli HS (pFamp) R as the host. Plaque assays
were performed in triplicate and 1000 ml of secondary effluent was spiked
with MS2 to a final concentration of 1 x 105 PFU/mL. Three trials were
completed, each trial containing a sample size of n=3. The mean LRV of
MS2, when magnetite was not a d d e d , was 1.8040, with a standard
deviation of 0.3280. The mean LRV of MS2 when magnetite was a d d e d
was 2.9638, with a standard deviation of 0.1217. A p value 0.005 (a=0.05)
was obtained, which indicates that there is a statistically significant
difference in the removal of MS2, from the secondary effluent samples,
when magnetite is present versus when it is not. In Figure 7, the upper
whisker extends to the maximum data point, for each category, and the
lower whisker extends to the minimum data point. Each colored box
contains the middle 50% of the d a t a . The line, within each box, illustrates
the median. The plus sign, within each colored box, represents the mean.
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Removal of MS2 Using the Bench Scale Model of the CoMgq™ Process

The removal of MS2, using a bench scale model of the CoMag™
process was evaluated. All trials were performed in triplicate. The LRV for
MS2 was calculated by dividing the final viral concentration (Nt) by the
initial viral concentration (No). These values were then logio transformed
[logio (N/No)], and the values for each of the three experiments were
averaged. The correlation was considered statistically significant at a 95%
confidence level.

Minitab version 15 was utilized to complete the

statistical analysis. The results of the three trials are summarized in Tables 3
and 4 and Figure 8.
The amount of endogenous MS2, present in the sample matrix, was
below the detectable limit of <1 PFU/mL

The average LRV for the

removal of MS2 was 3.0495 for trial 1, 2.9640 for trial 2, and 2.9525 for trial 3,
respectively. Statistical analysis was performed to evaluate the following
null hypothesis:

The LRV of MS2 does not vary between trials, to a

statistically significant degree. The statistical analysis resulted in p value of
0.890, indicating that there is not a significant difference when comparing
the removal of MS2 in each trial. Therefore, the null hypothesis that states
the LRV of MS2 does not vary significantly between trials fails to be
rejected.
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Table 3: One-way ANOVA: MS2 Mean LRV versus Trial
DF
SS
2
0.0112
3
0.1386
5
0.1498

Source
test
Error
Total

MS
0.0056
0.0462

F
0.12

P
0.890

S = 0.2150 R-Sq = 7.50% R-.5q(adj)=0.00%

Level
1
2
3

N
2
2
2

Mean
3.0495
2.9640
2.9525

StDev
0.2765
0.2489
0.0148

Individual 95% CIs For Mean Based on
Pooled StDev
+
+
+

+_

(

;

i

>

)
2.70

3.00

3.30

3.60

Pooled StDev = 0.2150

Table 4: Descriptive Statistics: MS2 Mean LRV versus Trial
Variable test
LRV
1
2
3

Total
Count
2
2
2

Mean
3.050
2.964
2.9525

StDev
0.2760
0.2490
0.0148

Sum of
Squares
18.6750
17.6330
17.4347

Minimum Median Maximum
2.8540
3.0500
3.2450
2.7880
2.9640
3.1400
2.9420
2.9525
2.9630

Data in Tables 3 and 4 represents the calculated LRV of MS2, using the
results from three separate trials. For each trail, the removal of MS2 was
assayed in triplicate. The plaque assays were also conducted in triplicate.
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Figure 8: Mean Log Reduction Value of MS2 for Three Trials at 24° C, Using
the Bench Scale Model of the CoMag™ Process
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The data in Figure 8 represents the average LRV for MS2, detected by
modified double agar overlay, using E. coli HS (pFamp) R as the host.
Plaque assays were performed in triplicate and 1000 ml of secondary
effluent was spiked with MS2 to a final concentration of 1 x 105 PFU/mL.
Three trials were completed, each trial containing a sample size of n=3.
The mean LRV of MS2 for trial 1 was 3.050, with a standard deviation of
0.276. The mean LRV of MS2 for trial 2 was 2.964, with a standard
deviation of 0.246. The mean LRV of MS2 for trial 3 was 2.953, with a
standard deviation of 0.015. A p value 0.890 (a=0.05) was obtained,
which indicates that there is no statistically significant difference in the
removal of MS2 among the three trails. Error bars corresponds to standard
error.
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Removal of MS2 Using the Bench Scale Model of the CoMaq™ Process at
24°C and 4°C

The removal of MS2, using a bench scale model of the CoMag™
process was evaluated at 24°C and 4°C. All trials were performed in
triplicate. The LRV for MS2 was calculated by dividing the final viral
concentration (Nt) by the initial viral concentration (No). These values
were then logio transformed [logio (N/No)], and the values from the
triplicate experiments were averaged.

The correlation was considered

statistically significant at a 95% confidence level. Minitab version 15 was
utilized to complete the statistical analysis.
The amount of endogenous MS2 present in the sample matrix was
below

the detectable

limit of

<1 PFU/mL. Statistical analysis was

performed to evaluate the following null hypotheses:

(1) The MS2 LRV

does not significantly vary, at 24° versus 4°C, when combined with
another virus (2) The MS2 LRV does not significantly vary, between trials at
the same temperature (24° or 4°C), when combined with another virus.
The LRV of MS2, at 24°C, was 2.9306 when combined with poliovirus type
1, 2.9756 when combined with rotavirus strain Wa, and 2.8336 when
combined with adenovirus type 2. Statistical analysis resulted in a p value
of 0.270, indicating that there is no significant difference in the removal of
MS2, when combined with poliovirus, rotavirus and adenovirus at 24°C.
Therefore, the null hypothesis stating that the MS2 LRV does
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not

significantly differ at 24°C, when combined with poliovirus, rotavirus or
adenovirus is not rejected. The results are summarized in Table 5 and 6
and Figure 9.
The LRV of MS2 at 4°C was 2.9885 when combined with poliovirus
type 1, 2.8872 when combined with rotavirus strain Wa, and 2.8944 when
combined with adenovirus type 2. Statistical analysis resulted in a p value
of 0.476, indicating that there is not a significant difference in the removal
of MS2, when combined with poliovirus, rotavirus or adenovirus at 4°C.
Therefore, the null hypothesis stating that the LRV of MS2 does not
significantly vary at 4°C, when combined with poliovirus, rotavirus or
adenovirus, fails to be rejected. The results are summarized in Table 7 and
8 and Figure 10.
At 24°C, the mean LRV of MS2, when combined with poliovirus,
rotavirus and adenovirus, was 2.9133 with a standard deviation of 0.1057.
At 4°C, the mean LRV of MS2, when combined with poliovirus, rotavirus
and adenovirus, was 2.9234 with a standard deviation of 0.1046.
Statistical analysis resulted in a p value of 0.841. Therefore; the null
hypothesis fails to be rejected, which states that the mean LRV of MS2
does not significantly vary, at 24° versus 4°C, when combined with
another virus. The results are summarized in Table 9 and 10 and Figure 11.
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Table 5: One-way ANOVA: Mean LRV of MS2 at 24°C
Source
Factor
Error
Total
S = 0.09809

DF
2
6
8

SS
0.03160
0.05773
0.08933
R-Sq = 35.38%

Level
N
MS2 24C (polio)
3
MS2 24C (rota)
3
MS2 24C (adeno) 3

Mean
2.9306
2.9756
2.8336

MS
0.01580
0.00962

F
1.64

P
0.270

R-Sq(adj) = 13.83%

StDev
0.0942
0.1358
0.0395

Individual 95% CIs For Mean Based on
Pooled StDev
—+
+
+
+—

—+_
2.76

.+—
2.88
3.00

.+—
3.12

Pooled StDev = 0.0981

Table 6: Descriptive Statistics: Mean LRV of MS2 at 24°C
Variable
N
MS2 24°C (poliovirus)
3
MS2 24°C (rotavirus)
3
MS2 24°C (adenovirus) 3

Mean
2.9306
2.9756
2.8336

StDev
0.0942
0.1358
0.0395

Minimum
2.8221
2.8451
2.8009

Median
2.9794
2.9656
2.8225

Maximum
2.9905
3.1161
2.8774

Data in Tables 5 and 6 represents the calculated LRV of MS2, using data
from three separate trials. For each trail, the removal of MS2 was assayed
in triplicate. The plaque assays were also conducted in triplicate.
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Figure 9: Mean Log Reduction Value of MS2 at 24°C Using the Bench Scale
Model of the CoMag™ Process
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The data represents the average LRV for MS2 at 24°C, detected by
modified double agar overlay, using E. co//-HS (pFamp) R as the host.
Plaque assays were performed in triplicate and 1000 ml of secondary
effluent was spiked with MS2 to a final concentration of 1 x 105 PFU/mL.
Three trials were completed, each trial containing a sample size of n=3.
The mean LRV of MS2, when challenged with poliovirus type 1, was 2.931
with a standard deviation of 0.0942. The mean LRV of MS2, when
challenged with rotavirus strain Wa, was 2.976 with a standard deviation
of 0.1358. The mean LRV of MS2, when challenged with adenovirus type 2,
was 2.834 with a standard deviation of 0.0395. A p value 0.270 (a=0.05)
was obtained, which indicates that there is no statistically significant
difference in the removal of MS2 when combined with poliovirus, rotavirus
and adenovirus. In Figure 9, the upper whisker extends to the maximum
data point, for each variable, and the lower whisker extends to the
minimum data point. Each colored box contains the middle 50% of the
data. The line within each box illustrates the median. The plus sign, within
each colored box, represents the mean.

72

Table 7: One-way ANOVA: Mean LRV of MS2 4°C
Source
Factor
Error
Total
S = 0.1068

DF
2
6
8

MS
0.0096
0.0114

SS
0.0192
0.0684
0.0876

R-Sq = 21.90%

Level
MS2 4°C (poliovirus)
MS2 4°C (rotavirus)
MS2 4°C (adenovirus)

N
3
3
3

F
0.84

P
0.476

R-Sq(adj) = 0.00%

Mean
2.9885
2.8872
2.8944

StDev
0.0800
0.1440
0.0841

Individual 95% CIs For Mean Based on
Pooled StDev
_+_
--)

Level
MS2 4°C (poliovirus)
MS2 4°C (rotavirus)
MS2 4°C (adenovirus)

2.76

—+_
2.88

3.00

3.12

Pooled StDev = 0.1068

Table 8: Descriptive Statistics: Mean LRV of MS2 4°C
Variable
MS2 4°C (poliovirus)
MS2 4°C (rotavirus)
MS2 4°C (adenovirus)

N
3
3
3

Mean StDev
2.9885 0.0800
2.8872 0.1440
2.8944 0.0841

Minimum
2.9055
2.7362
2.8053

Median
2.9950
2.9023
2.9055

Maximum
3.0650
3.0231
2.9723

Data in Tables 7 and 8 represents the calculated LRV of MS2, using data
from three separate trials. For each trail, the removal of MS2 was assayed
in triplicate. The plaque assays were also conducted in triplicate.
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Figure 10: Mean Log Reduction Value of MS2 at 4°C Using the Bench Scale
Model of the CoMag™ Process
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The data represents the average LRV for MS2 at 4°C, detected by
modified double agar overlay, using E. coli HS (pFamp) R as the host.
Plaque assays were performed in triplicate and 1000 ml of secondary
effluent was spiked with MS2 to a final concentration of 1 x 105 PFU/mL.
Three trials were completed, each trial containing a sample size of n=3.
The mean LRV of MS2, when challenged with poliovirus type 1, was 2.989
with a standard deviation of 0.080. The mean LRV of MS2, when
challenged with rotavirus strain Wa, was 2.887 with a standard deviation
of 0.144. The mean LRV of MS2, when challenged with adenovirus type 2,
was 2.894 with a standard deviation of 0.084. A p value 0.476 (a=0.05)
was obtained, which indicates that there is no statistically significant
difference in the removal of MS2 when combined with poliovirus, rotavirus
and adenovirus. In Figure 10, the upper whisker extends to the maximum
data point, for each variable, and the lower whisker extends to the
minimum data point. Each colored box contains the middle 50% of the
data. The line within each box illustrates the median. The plus sign, within
each colored box, represents the mean.
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Table 9: One-way ANOVA: Mean LRV of MS2 at 24°C and 4°C
Source
Factor
Error
Total

DF
1
16
17

S = 0.1052

Level
MS2 24°C
MS2 4°C

SS
0.0005
0.1769
0.1774

R-Sq = 0.26%

N
9
9

MS
0.0005
0.0111

F
0.04

P
0.841

R-Sq (adj) = 0.00%

Mean StDev
2.9133 0.1057
2.9234 0.1046

Individual 95% CIs For Mean Based on Pooled StDev
+
+
+
+
(
*
)
(
*
)
+
+
+
+
2.840 2.880 2.920 2.960

Pooled StDev = 0.1052

Table 10: Descriptive Statistics: Mean LRV of MS2 at 24°C and 4°C
Variable
MS2 24°C
MS2 4°C

N
9
9

Mean
2.9133
2.9234

StDev
0.1057
0.1046

Minimum
2.8009
2.7362

Median
2.8774
2.9055

Maximum
3.1161
3.0650

Data in Tables 9 and 10 represents the calculated LRV of MS2, using data
from three separate trials. For each trail, the removal of MS2 was assayed
in triplicate. The plaque assays were also conducted in triplicate.
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Figure 11: Mean Log Reduction Value of MS2 when combined with
Poliovirus type 1, Rotavirus strain Wa and Adenovirus type 2 at 24°C and
4°C, Using the Bench Scale Model of the CoMag™ Process
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The data represents the average LRV for MS2, at 24°C and 4°C, detected
by modified double agar overlay, using E. coli HS (pFamp) R as the host.
Plaque assays were performed in triplicate and 1000 ml of secondary
effluent was spiked with MS2 to a final concentration of 1 x 105 PFU/mL.
Three trials were completed, each trial containing a sample size of n=3.
The mean LRV of MS2, when challenged at 24°C with poliovirus type 1,
rotavirus strain Wa, and adenovirus type 2 was 2.9133, with a standard
deviation of 0.1057. The mean LRV of MS2, when challenged at 4°C with
poliovirus type 1, rotavirus strain Wa, a n d adenovirus type 2 was 2.9234,
with a standard deviation of 0.1046.
A p value 0.841 (a=0.05) was
obtained, which indicates that there is no statistically significant difference
in the removal of MS2, when combined with poliovirus, rotavirus and
adenovirus at 24° versus 4°C. In Figure 11, the upper whisker extends to
the maximum data point, for each variable, and the lower whisker
extends to the minimum data point. Each colored box contains the
middle 50% of the data. The line, within each box, illustrates the median.
The plus sign, within each colored box, represents the mean.
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Removal of MS2, Poliovirus type 1, Rotavirus strain Wa and Adenovirus
type 2 Using the Bench Scale Model of the CoMaa™ Process at 24°C and
4°C

The removals of MS2, poliovirus type 1, rotavirus strain Wa and
adenovirus type 2, using a bench scale model of the CoMag™ process,
were evaluated at 24°C and 4°C. All trials were performed in triplicate.
The amount of endogenous MS2 present in the sample matrix was
below the detectable limit of <1 PFU/mL.

Statistical analysis was

performed to evaluate the following null hypotheses:

(1) there is no

statistically significant difference between the removal of poliovirus type 1,
rotavirus strain Wa, and adenovirus type 2 at 24°C versus 4°C (2) there is no
statistically significant difference between the removal of MS2 with
poliovirus type 1, MS2 with rotavirus strain Wa, and MS2 with adenovirus type 2
at 24°C or 4°C.

At 24°C, the LRV of MS2 was 2.9306 when combined with

poliovirus type 1, 2.9756 when combined with rotavirus strain Wa, and
2.8336 when combined with adenovirus type 2. At 4°C, The LRV of MS2
was 2.9885 when combined with poliovirus type 1, 2.8872 when combined
with rotavirus strain Wa, and 2.8944 when combined with adenovirus type
2.

The LRV of poliovirus was 3.5545 with a standard deviation of 0.0975,

at 24°C, and 3.2440 with a standard deviation of 0.1223, at 4°C. The results
are summarized in Tables 11 through 28 and Figures 12 through 20.
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The LRV of rotavirus was 3.5482 with a standard deviation of 0.1504,
at 24°C, and 3.5114 with a standard deviation of 0.1161, at 4°C. The results
are summarized in Tables 21 through 24 and Figures 17 and 18. The LRV of
adenovirus was 3.3.493, at 24°C, with a standard deviation of 0.1740 and
3.470 with a standard deviation of 0.2330, at 4°C. The results are
summarized in Tables 25 through 284 and Figures 19 and 20.
The statistical analysis evaluating the removal of MS2 in comparison
with poliovirus, rotavirus and adenovirus, at 24°C, resulted in p values of
0.001, 0.008, and 0.003 respectively. These p values indicate that there is a
significant difference in the removal of MS2 as well as poliovirus, rotavirus,
and adenovirus at 24°C. The statistical analysis evaluating the removal of
MS2, in comparison with poliovirus, rotavirus and adenovirus at 4°C,
resulted in p values of 0.039, 0.004, and 0.016 respectively. These p values
imply that there is a significant difference in the removal of MS2 and the
removal of poliovirus, rotavirus and adenovirus at 4°C. Therefore, the null
hypothesis stating that there is no statistically significant difference in the
removal of MS2 with poliovirus type 1, MS2 with rotavirus strain Wa, and MS2
with adenovirus type 2 at 24°C or 4°C is rejected.
The mean LRV of poliovirus, at 24°C, was 3.5545 with a standard
deviation of 0.0975. At 4°C, the mean LRV was 3.2440 with a standard
deviation of 0.1223.

Statistical analysis resulted in a p value of 0.026;
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therefore, the null hypothesis stating that poliovirus LRV does not
statistically vary, at 24° versus 4°C, is rejected. The mean LRV of rotavirus,
at 24°C, was 3.5482 with a standard deviation of 0.1504. At 4°C, the mean
LRV was 3.5144 with a standard deviation of 0.1161.

Statistical analysis

resulted in a p value of 0.774; therefore, the null hypothesis stating that
poliovirus LRV does not statistically vary, at 24° versus 4°C, fails to be
rejected. The mean LRV of adenovirus, at 24°C, was 3.493 with a standard
deviation of 0.1740. At 4°C, the mean LRV was 3.3.470 with a standard
deviation of 0.2330.

Statistical analysis resulted in a p value of 0.896

therefore; the null hypothesis stating that poliovirus LRV does not
statistically vary at 24° versus 4°C fails to be rejected.
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Table 11: One-way ANOVA: Mean LRV of Poliovirus at 24°C versus
Poliovirus at 4°C
Source
Factor
Error
Total

DF
1
4
5

SS
0.1446
0.0490
0.1936

MS
0.1446
0.0122

F
11.82

P
0.026

S = 0.1106 R-Sq = 74.71% R-Sq(adj) = 68.39%

Level
N
Poliovirus 24°C 3
Poliovirus 4°C 3

Mean
3.5545
3.2440

Individual 95% CIs For Mean Based on
Pooled StDev
StDev
+
+
+
+0.0975
(
*
)
0.1223
(
*
)
+
+
+
+._
3.20

3.40

3.60

3.80

Pooled StDev = 0.1106

Table 12: Descriptive Statistics: Mean LRV of Poliovirus at 24°C versus
Poliovirus at 4°C
Variable
Poliovirus 24°C
Poliovirus 4°C

N
3
3

Mean
3.5545
3.2440

StDev
0.0975
0.1223

Minimum
3.4735
3.1034

Median
3.5272
3.3022

Maximum
3.6628
3.3263

Data in Tables 11 and 12 represents the calculated LRV for poliovirus type
1, using data from three separate trials obtained when performing a
bench scale model of the CoMag™ process. For each trail, the removal
of poliovirus was assayed in triplicate. The plaque assays were also
conducted in triplicate.
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Figure 12: Mean Log Reduction Value of Poliovirus type l a t 24°C versus
the Mean Log Reduction Value of Poliovirus type 1 at 4°C, Using the Bench
Scale Model of the CoMag™ Process
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The data represents the average LRV for poliovirus type 1, at 24°C versus
4°C, using a bench scale model of the CoMdg™ process. Poliovirus type
1 was detected using a modified neutral red plaque-forming unit (PFU)
method, in BGMK cells. Plaque assays were performed in triplicate a n d
1000 ml of secondary effluent was spiked with poliovirus to a final
concentration of 1 x 105 PFU/mL. Three trials were completed; each trial
containing a sample size of n=3. The mean LRV of poliovirus, at 24°C, was
3.5545 with a standard deviation of 0.0975. The mean LRV of poliovirus, at
4°C, was 3.2440 with a standard deviation of 0.1223.
A p value 0.026
(a=0.05) was obtained, which indicates that there is a statistically
significant difference in the removal of poliovirus, at 24°C versus 4°C. In
Figure 12, the upper whisker extends to the maximum data point, for each
variable, a n d the lower whisker extends to the minimum data point. Each
colored box contains the middle 50% of the data. Each line within the box
illustrates the median. The plus sign, within each colored box, represents
the mean.
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Table 13: One-way ANOVA: Mean LRV of Rotavirus at 24°C versus
Rotavirus at 4°C
Source
Factor
Error
Total

DF
1
4
5

SS
0.0017
0.0722
0.0739

MS
0.0017
0.0181

F
0.09

P
0.774

S = 0.1344 R-Sq = 2.31% R-Sq(adj) = 0.00%

Level
N
Rotavirus 24°C 3
Rotavirus 4°C
3

Mean StDev
3.5482 0.1504
3.5144 0.1161

Individual 95% CIs For Mean Based on
Pooled StDev
—+
+
+
+—
(
*
)
(
*
)
—+
+
+
+—
3.36

3.48

3.60

3.72

Pooled StDev = 0.1344

Table 14: Descriptive Statistics: Mean LRV of Rotavirus at 24°C versus
Rotavirus at 4°C
Variable
N
Rotavirus 24°C 3
Rotavirus 4°C
3

Mean
3.5482
3.5144

StDev
0.1504
0.1161

Minimum
3.3881
3.3819

Median
3.5698
3.5631

Maximum
3.6866
3.5983

Data in Tables 13 and 14 represents the calculated LRV for rotavirus strain
Wa. Data were utilized that resulted from performing three separate trials,
using a bench scale model of the CoMag™ process. For each trail, the
removal rotavirus was assayed in triplicate. The plaque assays were also
conducted in triplicate.
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Figure 13: Mean Log Reduction Value of Rotavirus strain Wa at 24°C versus
Mean Log Reduction Value of Rotavirus strain Wa at 4°, Using the Bench
Scale Model of the CoMag™ Process
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The data represents the average LRV for rotavirus strain Wa at, 24°C versus
4°C, using a bench scale model of the CoMag™ process. Rotavirus strain
Wa was detected using a modified crystal violet plaque-forming unit (PFU)
method, with Ma-104 cells acting as the host.
Plaque assays were
performed in triplicate and 1000 ml of secondary effluent was spiked with
rotavirus to a final concentration of 1 x 105 PFU/mL. Three trials were
completed, each trial containing a sample size of n=3. At 24°C, the mean
LRV of rotavirus was 3.5482 with a standard deviation of 0.1504. At 4°C,
the mean LRV of rotavirus was 3.5144 with a standard deviation of 0.1161.
A p value of 0.7740 (a=0.05) was obtained, which indicates that there is
not a statistically significant difference in the removal of rotavirus at 24°C
versus 4°C. In Figure 13, the upper whisker extends to the maximum data
point, for each variable, and the lower whisker extends to the minimum
data point. Each colored box contains the middle 50% of the data. The
line within each box illustrates the median. The plus sign, within each
colored box, represents the mean.
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Table 15: One-way ANOVA: Mean LRV of Adenovirus at 24°C versus 4°C
Source
Factor
Error
Total

DF
1
4
5

SS
0.0008
0.1691
0.1699

MS
0.0008
0.0423

F
0.02

P
0.896

S = 0.2056 R-Sq = 0.48% R-Sq(adj) =0.00%

Level
N
Adenovirus 24°C 3
Adenovirus 4°C
3

Individual 95% CIs For Mean Based on
Pooled StDev
—+
+
+
+
(
*
)
(
*
)
—+
+
+
+

Mean StDev
3.4933 0.1739
3.4700 0.2330

3.20

3.40

3.60

3.80

Pooled StDev = 0.2056

Table 16: Descriptive Statistics: Mean LRV of Adenovirus at 24°C versus 4°C
Variable
Adenovirus 24°C
Adenovirus 4°C

N
3
3

Mean
3.4930
3.4700

StDev
0.1740
0.2330

Minimum
3.3600
3.2800

Median
3.4300
3.4000

Maximum
3.6900
3.7300

Data in Tables 15 and 16 represents the calculated LRV of adenovirus type
2, using data from gathered from three separate trials employing a bench
scale model of the CoMag™ process. For each trail, the removal
adenovirus was assayed in triplicate. The plaque assays were also
conducted in triplicate.
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Figure 14: Mean Log Reduction Value of Adenovirus type 2 at 24°C versus
the Mean Log Reduction Value of Adenovirus type 2 at 4°C, Using the
Bench Scale Model of the CoMag™ Process
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The data represents the average LRV for adenovirus type 2 at, 24°C versus
4°C, using a bench scale model of the CoMag™ process. Adenovirus
type 2 was detected using the Reed and Muench TCID50 method, with
A549 cells as the host. Plaque assays were performed in triplicate and
1000 ml of secondary effluent was spiked with adenovirus to a final
concentration of 1 x 105 TCID50/ mL. Three trials were completed, each
trial containing a sample size of n=3. The mean LRV of adenovirus, at
24°C, was 3.4933 with a standard deviation of 0.1740. The mean LRV of
rotavirus, at 4°C, was 3.4700 with a standard deviation of 0.2330.
A p
value 0.8960 (a=0.05) was obtained, which indicates that there is no
statistically significant difference in the removal of adenovirus at 24°C
versus 4°C. In Figure 14, the upper whisker extends to the maximum data
point, for each variable, and the lower whisker extends to the minimum
data point. Each colored box contains the middle 50% of the data. The
line within each box illustrates the median. The plus sign, within each
colored box, represents the mean.
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Table 17: One-way ANOVA: Mean LRV of MS2 at 24°C and Poliovirus at
24°C
Source
Factor
Error
Total

DF
1
4
5

SS
0.58375
0.03677
0.62052

MS
0.58375
0.00919

F
63.50

P
0.001

S = 0.09588 R-Sq = 94.07% R-Sq(adj) = 92.59%

Level
MS2 24°C
Poliovirus 24°C

N
3
3

Mean
2.9306
3.5545

StDev
0.0942
0.0975

Individual 95% CIs For Mean Based on
Pooled StDev
+
+
+
+

Level
MS2 24°C
Poliovirus 24°C

-)
_+
3.00

+_
3.25

.+—
3.50

-+
3.75

Pooled StDev = 0.0959

Table 18: Descriptive Statistics: Mean LRV of MS2 at 24°C and Poliovirus
24°C
Variable
MS2 24°C
Poliovirus 24°C

N
3
3

Mean
2.9306
3.5545

StDev
0.0942
0.0975

Minimum
2.8221
3.4735

Median
2.9794
3.5272

Maximum
2.9905
3.6628

Data in Tables 17 and 18 represents the calculated LRV of MS2 and
poliovirus type 1, at 24°C, using data from three separate trials, obtained
by performing a bench scale model of the CoMag™ process. For each
trail, the removal MS2 and poliovirus was assayed in triplicate. The plaque
assays were also conducted in triplicate.
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Figure 15: Mean Log Reduction Value of MS2 versus the Mean Log
Reduction Value of Poliovirus type 1 at 24°C, Using the Bench Scale Model
of the CoMag™ Process
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The data represents the average LRV of MS2 and poliovirus type 1, at
24°C, using a bench scale model of the CoMag™ process. MS2 and
poliovirus were spiked into the same test sample.
Three trials were
completed, each trial containing a sample size of n=3. The mean LRV of
MS2 was 2.9306 with a standard deviation of 0.10942. The mean LRV of
poliovirus was 3.5545 with a standard deviation of 0.0975. A p value
0.0010 (a=0.05) was obtained, which indicates that there is a statistically
significant difference in the removal of MS2 at 24°C and poliovirus at 24°C.
In Figure 15, the upper whisker extends to the maximum data point, for
each variable, and the lower whisker extends to the minimum data point.
Each colored box contains the middle 50% of the data. The line within
each box illustrates the median. The plus sign, within each colored box,
represents the mean.
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Table 19: One-way ANOVA: Mean LRV of MS2 at 4°C and Poliovirus at 4°C
Source
Factor
Error
Total

DF
1
4
5

SS
0.0979
0.0427
0.1406

MS
0.0979
0.0107

F
9.17

P
0.039

S = 0.1033 R-Sq = 69.62% R -Sq(adj) = 62.03%

N
Level
3
MS2 4°C
Poliovirus 4°C 3

Mean
2.9885
3.2440

Level
MS2 4°C
Poliovirus 4°C

StDev
0.0800
0.1223

Individual 95% CIs For Mean Based on
Pooled StDev
—+ +
+
+
(
--*
)
(
*
)
..+—
+
+
+
2.85
3.00
3.15
3.30

Pooled StDev = 0.1033

Table 20: Descriptive Statistics: Mean LRV of MS2 at 4°C and Poliovirus at
4°C
Variable
MS2 4°C
Poliovirus 4°C

N
3
3

Mean
2.9885
3.2440

StDev
0.0800
0.1223

Minimum
2.9055
3.1034

Median
2.9950
3.3022

Maximum
3.0650
3.3263

Data in Tables 19 and 20 represents the calculated LRV of MS2 and
poliovirus type 1, at 4°C, using data from three separate trials obtained by
performing a bench scale model of the CoMag™ process.' For each trail,
the removal MS2 and poliovirus was assayed in triplicate. The plaque
assays were also conducted in triplicate.
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Figure 16: Mean Log Reduction Value of MS2 versus the Mean Log
Reduction Value of Poliovirus type 1 at 4°C, Using the Bench Scale Model of
the CoMag™ Process
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The data represents the average LRV of MS2 and poliovirus type 1, at 4°C,
using a bench scale model of the CoMag™ process. One thousand
milliliters of secondary effluent was spiked with MS2 and poliovirus for a
target concentration of 1 x 105 PFU/mL and plaque assays were
performed. Three trials were completed, each trial containing a sample
size of n=3. The mean LRV of MS2 was 2.9885 with a standard deviation of
0.0800. The mean LRV of poliovirus was 3.2440 with a standard deviation
of 0.1223. A p value 0.0390 (a=0.05) was obtained, which indicates that
there is a statistically significant difference in the removal of MS2 at 4°C
a n d poliovirus at 4°C. In Figure 16, the upper whisker extends to the
maximum data point, for each variable, and the lower whisker extends to
the minimum data point. Each colored box contains the middle 50% of
the data. The line within each box illustrates the median. The plus sign,
within each colored box, represents the mean.
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Table 21: One-way ANOVA: Mean LRV of MS2 at 24°C and Rotavirus at
24°C
Source
Factor
Error
Total

DF
1
4
5

SS
0.4917
0.0821
0.5739

MS
0.4917
0.0205

F
23.95

P
0.008

S = 0.1433 R-Sq = 85.69% R-Sq(adj) = 82.11%
Level
MS2 24°C
Rotavirus 24°C

N
3
3

Mean
2.9756
3.5482

Level
MS2 24°C (rotavirus)
Rotavirus 24°C

StDev
0.1358
0.1504

Individual 95% CIs For Mean Based on
Pooled StDev
+
+
+
+(
*
)
(
*
1
+
+_
3.00
3.30
3.60
3.90

Pooled StDev = 0.1433

Table 22: Descriptive Statistics: Mean LRV of MS2 at 24°C and Rotavirus at
24°C
Variable
MS2 24°C
Rotavirus 24°C

N
3
3

Mean
2.9756
3.5482

StDev
0.1358
0.1504

Minimum
2.8451
3.3881

Median
2.9656
3.5698

Maximum
3.1161
3.6866

Data in Tables 21 and 22 represents the calculated LRV of MS2 and
rotavirus strain Wa, at 24°C, using data obtained from three separate trials
utilizing a bench scale model of the CoMag™ process. For each trail, the
removal MS2 and rotavirus was assayed in triplicate. The plaque assays
were also conducted in triplicate.
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Figure 17: Mean Log Reduction Value of MS2 versus the Mean Log
Reduction Value of Rotavirus strain Wa at 24°C, Using the Bench Scale
Model of the CoMag™ Process
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The data represents the average LRV of MS2 a n d rotavirus strain Wa, at
24°C, using a bench scale model of the CoMag™ process. One thousand
milliliters of secondary effluent was spiked with MS2 and rotavirus for a
target concentration of 1 x 105 PFU/mL a n d plaque assays were
performed. Three trials were completed; each trial containing a sample
size of n=3. The mean LRV of MS2 was 2.9756 with a standard deviation of
0.1358. The mean LRV of rotavirus was 3.5482 with a standard deviation of
0.1504. A p value of 0.0080 (a=0.05) was obtained, which indicates that
there is a statistically significant difference in the removal of MS2 at 24°C
and rotavirus at 24°C. In Figure 17, the upper whisker extends to the
maximum data point, for each variable, and the lower whisker extends to
the minimum data point. Each colored box contains the middle 50% of
the data. The line within each box illustrates the median. The plus sign,
within each colored box, represents the mean.
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Table 23: One-way ANOVA: Mean LRV of MS2 at 4°C and Rotavirus at 4°C
Source
Factor
Error
Total

DF
1
4
5

SS
0.5902
0.0685
0.6586

MS
0.5902
0.0171

F
34.49

P
0.004

S = 0.1308 R-Sq = 89.61% R-Sq(adj) = 87.01%

Level
N
MS2 4°C
3
Rotavirus 4°C 3

Mean
2.8872
3.5144

StDev
0.1440
0.1161

Individual 95% CIs For Mean Based on
Pooled StDev
-+
+
+
+
(
*
)
(
*
)
.+
+
+
+

Level
MS2 4°C (rotavirus)
Rotavirus 4°C

2.70

3.00

3.30

3.60

Pooled StDev = 0.1308

Table 24: Descriptive Statistics: Mean LRV of MS2 at 4°C and Rotavirus at
4°C
Variable
N
MS2 4°C
3
Rotavirus 4°C 3

Mean
2.8872
3.5144

StDev
0.1440
0.1161

Minimum
2.7362
3.3819

Median
2.9023
3.5631

Maximum
3.0231
3.5983

Data in Tables 23 and 24 represents the calculated LRV of MS2 and
rotavirus strain Wa, at 4°C, utilizing data obtained from three separate
trials utilizing a bench scale model of the CoMag™ process. For each
trail, the removal MS2 and rotavirus was assayed in triplicate. The plaque
assays were also conducted in triplicate.
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Figure 18: Mean Log Reduction Value of MS2 versus the Mean Log
Reduction Value of Rotavirus strain Wa at 4° Using the Bench Scale Model
of the CoMag™ Process
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The data represents the average LRV of MS2 a n d rotavirus strain Wa, at
4°C, using a bench scale model of the CoMag™ process. One thousand
milliliters of secondary effluent was spiked with MS2 and rotavirus for a
target concentration of 1 x 105 PFU/mL and plaque assays were
performed. Three trials were completed, each trial containing a sample
size of n=3. The mean LRV of MS2 was 2.8872 with a standard deviation of
0.1440. The mean LRV of rotavirus was 3.5144 with a standard deviation of
0.1161. A p value of 0.0040 (a=0.05) was obtained, which indicates that
there is a statistically significant difference in the removal of MS2 at 4°C
and rotavirus at 4°C. In Figure 18, the upper whisker extends to the
maximum data point, for each variable, and the lower whisker extends to
the minimum data point. Each colored box contains the middle 50% of
the data. The line within each box illustrates the median. The plus sign,
within each colored box, represents the mean.
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Table 25: One-way ANOVA: Mean LRV of MS2 at 24°C and Adenovirus at
24°C

S = 0.1261

DF
1
4
5

SS
0.6528
0.0636
0.7164

MS
0.6528
0.0159

u_

Source
Factor
Error
Total

P
0.003

41.07

R-Sq = 91.13% R-Sq(adj) = 88.91%

Level
MS2 24°C
Adenovirus 24°C

N
3
3

Level
MS2 24°C
Adenovirus 24°C

Individual 95% CIs For Mean Based on
Pooled StDev
..+
+
+
+
(--*
)
(-—*
)

..+
2.70

Mean
2.8336
3.4933

StDev
0.0395
0.1739

+

+

3.00

3.30

+
3.60

Pooled StDev = 0.1261

Table 26: Descriptive Statistics: Mean LRV of MS2 at 24°C and Adenovirus
at 24°C
Variable
MS2 24°C
Adenovirus 24°C

N
3
3

Mean
2.8336
3.4930

StDev
0.0395
0.1740

Minimum
2.8009
3.3600

Median
2.8225
3.4300

Maximum
2.8774
3.6900

Data in Tables 25 and 26 represents the calculated LRV of MS2 and
adenovirus type 2, at 24°C, using data from three separate trials that
utilized a bench scale model of the CoMag™ process. For each trail, the
removal MS2 and adenovirus was assayed in triplicate. The plaque assays
were also conducted in triplicate.
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Figure 19: Mean Log Reduction Value of MS2 versus the Mean Log
Reduction Value of Adenovirus type 2 at 24°C, Using the Bench Scale
Model of the CoMag™ Process
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The data represents the average LRV of MS2 and adenovirus type 2, at
24°C, using a bench scale model of the CoMag™ process. One thousand
milliliters of secondary effluent was spiked with MS2 and adenovirus for a
target concentration of 1 x 105 PFU/mL and plaque assays were
performed. Three trials were completed; each trial containing a sample
size of n=3. The mean LRV of MS2 was 2.8336 with a standard deviation of
0.0395. The mean LRV of adenovirus was 3.4930 with a standard deviation
of 0.1740.
A p value of 0.0030 (a=0.05) was obtained, which indicates
that there is a statistically significant difference in the removal of MS2 at
24°C and adenovirus at 24°C. In Figure 19, the upper whisker extends to
the maximum data point, for each variable, and the lower whisker
extends to the minimum data point. Each colored box contains the
middle 50% of the data. The line within each box illustrates the median.
The plus sign, within each colored box, represents the mean.
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Table 27: One-way ANOVA: Mean LRV of MS2 at 4°C and Adenovirus at
4°C
Source
Factor
Error
Total

DF
SS
1
0.4970
0.1227
4
0.6198
5

MS
0.4970
0.0307

F
P
16.20 0.016

S = 0.1752 R-Sq = 80.20% R-Sq(adj) = 75.24%

Level
MS2 4°C
Adenovirus 4°C

N
3
3

Mean
2.8944
3.4700

StDev
0.0841
0.2330

Individual 95% CIs For Mean Based on
Pooled StDev
—+
+
+
+

Level
MS2 4°C
Adenovirus 4°C

(
_+2.70

*

)

(
+ - —+3.00
3.30

*
—+
3.60

)

Pooled StDev = 0.1752

Table 28: Descriptive Statistics: Mean LRV of MS2 at 4°C and Adenovirus
at4°C
Variable
MS2 4°C
Adenovirus 4°C

N
3
3

Mean
2.8944
3.4700

StDev
0.0841
0.2330

Minimum
2.8053
3.2800

Median
2.9055
3.4000

Maximum
2.9723
3.7300

Data in Tables 27 and 28 represents the calculated LRV of MS2 and
adenovirus type 2 at 4°C, using data from three separate trials, which
utilized a bench scale model of the CoMag™ process. For each trail, the
removal MS2 and adenovirus was assayed in triplicate. The plaque assays
were also conducted in triplicate.
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Figure 20; Mean Log Reduction Value of MS2 versus the Mean Log
Reduction Value of Adenovirus type 2 at 4°C, Using the Bench Scale of the
CoMag™ Process
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The data represents the average LRV of MS2 and adenovirus type 2, at
4°C, using a bench scale model of the CoMag™ process. One thousand
milliliters of secondary effluent was spiked with MS2 a n d adenovirus for a
target concentration of 1 x 105 PFU/mL and plaque assays were
performed. Three trials were completed; each trial containing a sample
size of n=3. The mean LRV of MS2 was 2.8944 with a standard deviation of
0.0841. The mean LRV of adenovirus was 3.4700 with a standard deviation
of 0.2330.
A p value of 0.0160 (a=0.05) was obtained, which indicates
that there is a statistically significant difference in the removal of MS2 at
4°C and adenovirus at 4°C. In Figure 20, the upper whisker extends to the
maximum data point, for each variable, and the lower whisker extends to
the minimum data point. Each colored box contains the middle 50% of
the data. The line within each box illustrates the median. The plus sign,
within each colored box, represents the mean.
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Removal of MS2 Using the Bench Scale Model of the CoMag™ versus the
Removal of MS2 using the CoMaa™ Pilot Plant
The removal of MS2 using a bench scale model of the CoMag™
process was compared to the removal of MS2 utilizing the 100 gpm
CoMag™ pilot plant.

All trials were performed in triplicate. For the pilot

plant challenge, MS2 was spiked into 15L of sterile water, yielding a final
concentration of 3.37 x 106 PFU/mL.

The CoMag™ process was then

applied.
The amount of endogenous MS2, present in the sample matrix, was
below the detectable limit of <1 PFU/mL. An average 62 PFU/ mL was
detected in the influent of the CoMag™ pilot plant, which was later
normalized in the calculations.

Statistical analysis was performed to

evaluate the following null hypotheses:

(1) the pilot plant scale of the

CoMag™ process does not have a statistically significant effect on the
removal of MS2 between trails (2) there is no statistically significant
difference between the removal of MS2, using the pilot plant scale
CoMag™ process versus the bench scale model of the CoMag™ process.
The average LRV for the removal of MS2, using the bench scale
model, was 2.913 at 24°C. The average LRV for the removal of MS2 using
the Bench scale model, at 4°C, was 2.9234.

The average LRV for the

removal of MS2, using the pilot plant, was 2.0967. The statistical analysis
resulted in a p value of 0.000, at both 24°C and 4°C , indicating that there
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is a significant difference in the removal of MS2, using the bench scale
model versus the pilot plant. Therefore, the null hypothesis stating there is
no statistically significant difference in the removal of MS2, using the pilot
plant scale CoMag™ process versus the bench scale model of the CoMag™
process is rejected. The results are summarized in Tables 31 through 34 and
Figures 22 and 23.
Regarding the CoMag™ pilot plant, the mean LRV for MS2 was
2.1076 for trial 1, 2.0765 for trial 2, and 2.1064 for trial 3, respectively. The
results are summarized in Tables 29 and 30 and Figures 21. A p value 0..786
(a=0.05) was obtained, which indicates that there is no statistically
significant difference in the removal of MS2, between trails, when using
the CoMag™ pilot plant. Therefore, the null hypothesis stating that the
pilot plant scale of the CoMag™ process does not have a statistically
significant effect on the removal of MS2, between trails, fails to be
rejected.

A Tukey family error rate was conducted to analyze any

significant pairwise differences between level means. From this analysis, it
was concluded that no statistically significant pairwise interactions exist
among the means.
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Table 29: Two-way ANOVA: Pilot Plant Mean LRV versus Trial and Test
Source
MS2 lest
MS2 replicate
Error
Total
S = 0.1438

SS
0.011234
0.097283
0.041330
0.149847

DF
2
1
2
5

MS
0.0056172
0.0972827
0.0206652

F
0.27
4.71

P
0.786
0.162

R-Sq = 72.42% R-Sq(adj) = 31.05%

Individual 95% CIs For Mean Based on Pooled StDev
test Mean
.+
+_
1 3.0495
*
2 2.9640
3
2.9525
—+
2.75
3.00
3.25
3.50
MS2

MS2
replicate
1
2

Individual 95% CIs For Mean Based on Pooled StDev
+
+
+
+
*
)
(

Mean
2.86133
3.11600

2.50

2.75

-+3.00

...+—
3.25

Table 30: Tukey 95% Simultaneous Confidence Intervals: All Pairwise
Comparisons of Pilot Plant Mean LRV
Individual confidence level = 97.94%
Run 1 subtracted from:

Run 2
Run 3

Lower
-0.2992
-0.2693

Center
-0.0311
-0.0012

Upper
0.2371
0.2670

+—

.+_.

-0.30

-0.15

0.00

0.15

Run 2 subtracted from:

Run 3

Lower
-0.2382

Center
0.0299

Upper
0.2980

_+

-0.30

-0.15

-+0.00

+_
—+_
0.15

The data in Tables 29 and 30 represents the calculated LRV of MS2, using
data from three separate trials which employed a pilot plant model of the
CoMag™ process. In each trail, the removal of MS2 was assayed in
triplicate. The plaque assays were also conducted in triplicate.
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Figure 21: Mean Log Reduction Value of MS2 Using the CoMag™ Pilot
Plant
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The d a t a represents the average LRV for MS2, using the pilot scale
CoMag™ process. MS2 was detected by modified double agar overlay,
using E. coli HS (pFamp) R as the host. Plaque assays were performed in
triplicate and 1000 ml of secondary effluent was spiked with MS2 to a final
concentration of 1 x 105 PFU/mL. Three trials were completed, each trial
containing a sample size of n=3. The mean LRV was 2.1076 for trial 1,
2.0765 for trial 2, and 2.1064 for trial 3. A p value of 0.941 (a=0.05) was
obtained, which indicates that there is not a statistically significant
difference in the removal of MS2, between trails, when using the CoMag™
pilot plant. In Figure 21, the upper whisker extends to the maximum data
point, for each variable, and the lower whisker extends to the minimum
data point. Each colored box contains the middle 50% of the data. The
line within each box illustrates the median. The plus sign, within each
colored box, represents the mean.
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Table 31: One-way ANOVA: MS2 Bench Scale Mean LRV at 24°C a n d Pilot
Plant Mean LRV
Source
Factor
Error
Total
S = 0.1351

DF
3
20
23

SS
3.7828
0.3651
4.1478

R-Sq = 91.20% R-Sq(adj) = 89.88%

N
3
3
3
15

Level
MS2 24°C (poliovirus)
MS2 24°C (rotavirus)
MS2 24°C (adenovirus)
LRV

Level
MS2 24°C
MS2 24°C
MS2 24°C
Pilot Plant

MS
F
P
1.2609 69.08 0.000
0.0183

Mean
2.9306
2.9756
2.8336
2.0967

StDev
0.0942
0.1358
0.0395
0.1482

Individual 95% CIs For Mean Based on
Pooled StDev
+
+
— + — —+
(--*--)

(poliovirus)
(rotavirus)
(adenovirus)
LRV

(—*-")
(--*
)

K-)
—+
2.10

+
2.40

+
2.70

+—
3.00

Pooled StDev = 0.1351

Table 32: Descriptive Statistics: MS2 Mean LRV at 24°C a n d Pilot Plant
Mean LRV
Variable
MS2 24°C
MS2 24°C
MS2 24°C
Pilot Plant

(poliovirus)
(rotavirus)
(adenovirus)
LRV

N
3
3
3
15

Mean
2.9306
2.9756
2.8336
2.0967

StDev
0.0942
0.1358
0.0395
0.1482

Minimum
2.8221
2.8451
2.8009
1.7100

Median
2.9794
2.9656
2.8225
2.0900

Maximum
2.9905
3.1161
2.8774
2.3400

Data in Tables 31 a n d 32 represents the calculated LRV of MS2, utilizing
data from three separate trials comparing a bench scale model a n d a
pilot plant model of the CoMag™ process. For each trail, the removal of
MS2 was assayed in triplicate. The plaque assays were also conducted in
triplicate.
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Figure 22: Mean Log Reduction Value of MS2 at 24°C, Using the Bench
Scale Model of the CoMag™ Process, versus the Mean Log Reduction
Value of the CoMag™ Pilot Plant
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The data represents the average LRV for MS2, at 24°C, using a bench
scale model of the CoMag™ process versus the pilot scale CoMag™
process. MS2 was detected by modified double agar overlay, using E.
coli HS (pFamp) R as the host. Plaque assays were performed in triplicate
and 1000 ml of secondary effluent was spiked with MS2 to a final
concentration of 1 x 105 PFU/mL. Three trials were completed, each trial
containing a sample size of n=3. When challenged with poliovirus type 1,
the mean LRV of MS2, was 2.931, with a standard deviation of 0.0942. The
mean LRV of MS2, when challenged with rotavirus strain Wa, was 2.9756
with a standard deviation of 0.136.
The mean LRV of MS2, when
challenged with adenovirus type 2, was 2.8336 with a standard deviation
of 0.0395. When challenged at the CoMag™ pilot plant, the mean LRV of
MS2 was 2.097 with a standard deviation of 0.148. A p value of 0.000
(a=0.05) was obtained, which indicates that there is a statistically
significant difference in the removal of MS2, using the bench scale model
versus the pilot plant trial. In Figure 22, the upper whisker extends to the
maximum data point, for each variable, a n d the lower whisker extends to
the minimum data point. Each colored box contains the middle 50% of
the data. The line within each box illustrates the median. The plus sign,
within each colored box, represents the mean.
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Table 33: One-way ANOVA: MS2 Bench Scale Mean LRV at 4°C and Pilot
Plant LRV
Source
Factor
Error
Total

DF
3
20
23

SS
3.8635
0.3758
4.2393

MS
1.2878
0.0188

F
68.55

P
0.000

S = 0.1371 R-Sq = 91.14% R-Sq(adj) = 89.81%

Level
MS2 4°C (poliovirus)
MS2 4°C (rotavirus)
MS2 4°C (adenovirus)
Pilot Plant LRV

N
3
3
3
15

Mean
2.9885
2.8872
2.8944
2.0967

StDev
0.0800
0.1440
0.0841
0.1482
Individual 95% CIs For Mean Based on
Pooled StDev
+ - ~+
+— — +
(--*--)
(--*---)
(--*---)
(-*-)
-+~ — + . . + — + —
2.10
2.40 2.70 3.00

Level
MS2 4°C (poliovirus)
MS2 4°C (rotavirus)
MS2 4°C (adenovirus)
Pilot Plant LRV

Pooled StDev = 0.1371

Table 34: Descriptive Statistics: MS2 Bench Scale Mean LRV at 4°C and
Pilot Plant LRV
Variable
MS2 4°C (poliovirus)
MS2 4°C (rotavirus)
MS2 4°C (adenovirus)
Pilot Plant LRV

N
3
3
3
15

Mean
2.9885
2.8872
2.8944
2.0967

StDev
0.0800
0.1440
0.084.1
0.1482

Minimum
2.9055
2.7362
2.8053
1.7100

Median
2.9950
2.9023
2.9055
2.0900

Maximum
3.0650
3.0231
2.9723
2.3400

Data in Tables 33 and 34 represents the calculated LRV of MS2, utilizing
data from three separate trials, comparing a bench scale model and a
pilot plant model of the CoMag™ process. For each trail, the removal of
MS2 was assayed in triplicate. The plaque assays were also conducted in
triplicate.
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Figure 23: Mean Log Reduction Value of MS2 at 4°C, Using the Bench Scale
Model of the CoMag™ Process versus, the Mean Log Reduction of the
CoMag™ Pilot Plant
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The data represents the average LRV for MS2, at 4°C, using a bench scale
model of the CoMag™ process versus the pilot- scale CoMag™ process.
MS2 was detected by modified double agar overlay, using £. coli HS
(pFamp) R as the host. Plaque assays were performed in triplicate and
1000 ml of secondary effluent was spiked with MS2 to a final
concentration of 1 x 105 PFU/mL. Three trials were completed, each trial
containing a sample size of n=3. The mean LRV of MS2, when challenged
with poliovirus type 1, was 2.989 with a standard deviation of 0.080. The
mean LRV of MS2, when challenged with rotavirus strain Wa, was 2.887
with a standard deviation of 0.144. The mean LRV of MS2, when
challenged with adenovirus type 2, was 2.894 with a standard deviation of
0.084. The mean LRV of MS2, when challenged at the CoMag™ pilot
plant, was 2.097 with a standard deviation of 0.148. A p value of 0.000
(a=0.05) was obtained, which indicates that there is a statistically
significant difference in the removal of MS2 using the bench scale model
versus the pilot plant process. In Figure 23, the upper whisker extends to
the maximum data point, for each variable, and the lower whisker
extends to the minimum data point. Each colored box contains the
middle 50% of the data. The line within each box illustrates the median.
The plus sign, within each colored box, represents the mean.
105

CHAPTER IV

DISCUSSION

An increasing number of municipal wastewater treatment facilities
in the United States are now required to perform tertiary treatment of
wastewater. The move beyond primary and secondary treatment is being
implemented to achieve the more stringent parameters enforced by the
Environmental Protection Agency for the removal of containments such
as nutrients, toxic

compounds

and

suspended solids.

One

such

contaminant is phosphorus which is normally in short supply in freshwater
systems, however it is abundant in primary and secondary effluent,
because fecal waste contains

high

levels of

phosphorous. If the

phosphorus content of the water released by a treatment plant is not
limited algal blooms may develop resulting in eutrophication which may
lead to deaths of ponds, lakes and rivers.
The supply of phosphorus varies depending on the location of the
watershed, human activities and nonpoint sources.

The phosphorus

loading from nonpoint sources, such as agriculture runoff is minimal in the
summer due to a smaller number of rain events. The discharge of treated
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wastewater can be the most significant contributor to the phosphorus
levels in freshwater during the summer months. To deal with this issue, the
Environmental Protection Agency is requiring some wastewater treatment
facilities to reduce their phosphorus discharge during the summer months.
In 2006, the Concord MA Wastewater Treatment Facility's (WWTF) National
Pollutant Discharge Elimination System (NPDES) permit required

the

phosphorus level of their effluent to be reduced from 0.75 to 0.20 mg/L
(EPA, 2006b).

With existing alum addition to secondary effluent, the

Concord WWTF was only able to reduce the phosphorus level to between
0.6 and 0.7 mg/L. An alternate form of tertiary treatment with a small
footprint and low operation and maintenance costs was necessary to
achieve the 0.2 mg/L phosphorus goal. The Concord WWTF is currently
assessing the feasibility of the CoMag™ process to achieve phosphorus
levels required by the new NPDES permit because the process has proved
particularly effective at removing phosphorus at several other wastewater
treatment facilities (Cambridge Water Technology. 2007).
The CoMag™ process is capable of effectively removing a variety
of substances from water via high gradient magnetic separation (HGMS).
All

particles

are

classified

as

ferromagnetic,

paramagnetic,

diamagnetic, based on their magnetic susceptibility.

or

The magnetic

susceptibility of a material determines its recovery from water or removal
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as a waste product.

The CoMag™ process separates weakly magnetic

and non-magnetic particles facilitated by the addition of particles that
possess a high magnetic susceptibility to form aggregates of diamagnetic
particles.

Viruses are diamagnetic particles, and they may therefore be

removed from water using HGMS. A favorable aspect of the CoMag™
process is the potential for pathogen removal, especially viruses. While
the original intention of the CoMag™ process was phosphorus removal,
this study examined the possible use of the process for the removal of
viruses in a bench model and at the pilot plant.
The isoelectric point of magnetite is 7.5 ± 0.5. Therefore, under
acidic conditions, the surface of magnetite displays a net positive charge,
which attracts negatively charged material. When the pH is elevated to
alkaline conditions, the surface of magnetite becomes negatively
charged and any previously attached negatively charged material is
repelled.

Thus, as a result of the inherent magnetic properties of

magnetite at an acidic pH, it functions as an adsorbent for negatively
charged colloids, organic materials, bacteria and viruses (Anderson et al.,
1982).

MS2, poliovirus, rotavirus, and adenovirus behave as charged

colloids in an ionic environment because of their small size.

If the

isoelectric point of a virus differs from the isoelectric point of magnetite
the pH may be adjusted to facilitate electrostatic binding of viral particles
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to magnetite by compelling the magnetite to adopt an opposite charge.
The pH for the bench top scale CoMag™ process was optimized
using MS2 as the challenge virus. Several experiments were conducted with
the pH ranging from 3.0 to 8.0 and the optimum pH at which the LRV for
magnetite was the highest was determined to be pH 6.0 +\- 0.1

CoMag™ Bench Scale

CoMag™ is a magnetically enhanced technique for the removal of
contaminants from wastewater.

The CoMag™ process begins by passing

influent wastewater through a pre-conditioning magnetic matrix, in order to
create a locally induced magnetic moment or force, which is sensed by
colloidal particles. The electrostatic charge present on each particle that
passes through the pre-conditioning filter prevents aggregation of the
colloids. Also, the thermal motion of each particle offsets its gravitational
potential energy, resulting in random collisions.

The target pH range of the

pilot plant was broader (5.5 to 6.1) than the target pH range at the bench
scale (6.0 +/- 0.1) because of factors, such as heavy metals and salts, which
influence the pH of the wastewater flowing through the pilot plant. Because
the bench scale model used a single sample of secondary effluent and the
volume was constant, the pH was easily manipulated and the pH range
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could be narrower.
Bench scale experiments provide valuable information in a
controlled environment regarding the inactivation and removal of viruses.
There are limitations to bench scale experiments however, because the
seeded virus may not truly represent the conditions of those occurring
naturally in wastewater. For instance, viruses naturally present in sewage
may be encapsulated in cell debris, aggregated, or adhered to solid
particles. This, in turn, may prevent the virus from adhering to flocculants
or coagulants.
The physical removal of a virus from wastewater is determined by its
surface structure and isoelectric point, the pH of the wastewater, and the
degree of aggregation.

The behavior of flocculants, coagulants, and

magnetite toward viral particles depends on the composition, surface
chemistry, and isoelectric point of the particles. In addition, the pH and
composition of the wastewater are also important factors in the
adsorption of viruses.
The ideal matrix for this study would be one without variability and
inhibitory substances such as reverse osmosis water. However, since the
ultimate goal of this study was to evaluate a wastewater treatment
process for the removal of viruses, it was necessary to choose wastewater
as the matrix for the bench scale studies. Although the variability of

no

wastewater cannot be completely eliminated, the differences in virus
removal were attributed to variability of viral response to the CoMag™
process as opposed to variability in the content of the wastewater for
these particular bench scale studies. The inconsistent characteristics of
wastewater, such as biochemical oxygen demand and total suspended
solids, were minimized by using one batch of secondary effluent for all
bench scale experiments. The minimization of this variability was more
important than the limitations resulting from the use of a single grab
sample of wastewater for all experiments.

MS2

MS2 coliphage is non-pathogenic to humans and is commonly
found in environments where fecal contamination is present.

MS2 is

frequently used as a model or surrogate to evaluate the removal of
enteric viruses because it closely resembles them in size, structure, and
survival rate in the environment.
The removal of MS2 from secondary effluent wastewater was
evaluated, using a bench scale model of the CoMag™ process, without
added magnetite and at room temperature (24°C). The average LRV for
the removal of MS2, using the CoMag™ process, with the addition of

ill

magnetite, was 1.1598 logs higher then the removal of MS2 without
magnetite.

The statistical analysis displayed in Table 1 and Table 2

demonstrate a p value of 0.005, indicating that there is a significant
difference in the removal of MS2, when magnetite is a d d e d , versus when
magnetite is not a d d e d .

Regarding the data, it can be concluded that

the addition of magnetite has an enhanced effect on the removal of
MS2.
The robustness of the MS2 removal was also evaluated. This
was achieved by determining that the mean LRV did not significantly
differ for three trials performed on three different days. As presented in
Figure 8, the average LRV for the removal of MS2 was 3.0495 for trial 1,
2.9640 for trial 2, and 2.9525 for trial 3. A one-way unstacked ANOVA
resulted in a p value of 0.890, indicating that there is not a significant
difference, when comparing the removal of MS2 in each trial. The
removal a n d enumeration of MS2 is therefore considered robust.
To determine if temperature had a significant effect on the removal
of

MS2 two

temperatures

were

examined: 4°C

and

24°C.

This

temperature range reflects the anticipated conditions at the Concord,
MA plant. For each of the experiments, MS2 and one of the three enteric
viruses (poliovirus type 1, rotavirus strain Wa a n d adenovirus type 2) were
spiked simultaneously into the wastewater and evaluated. The paired
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comparisons were advantageous because they minimized variability,
which would have affected the comparison of the viral removals.
Statistical analysis resulted in a p value of 0.270, indicating that there is no
significant difference in the removal of MS2, when in the presence of
poliovirus, rotavirus, or adenovirus at 24°C.

These results are shown in

Tables 5 and 6. At 4°C, statistical analysis resulted in a p value of 0.476,
indicating that there is not a significant difference in the removal of MS2,
when in the presence of poliovirus, rotavirus, or adenovirus at 4°C.

The

results are shown in Tables 7 and 8.
Statistical analyses, as displayed in Figures 9 and 10, illustrate that
the removal of MS2 does not vary significantly, at 24° versus 4°C, when in
the presence of another virus. The adsorption of MS2 appears to be a
physical process which is independent of temperature and presence of
poliovirus type 1, rotavirus strain Wa and adenovirus type 2 under the
conditions tested for this research.
The removal of MS2 from the secondary effluent samples, using the
bench scale process, was significantly higher than the removal of poliovirus
type 1, rotavirus strain Wa, and adenovirus type 2. These results are displayed
in Figures 15 through 20. This conclusion can be attributed to the differing
isoelectric points of the four viruses. The isoelectric points of poliovirus type 1,
rotavirus strain Wa and adenovirus type 2 are higher than the isoelectric point
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of MS2 which is 3.9 (Dowd et al., 1997). MS2 is more strongly electronegative
in the pH range of the bench scale CoMag™ process (pH 6.0 +/- 0.1)
therefore its attachment to the positively charged magnetite is higher
than the attachment of the other three viruses.

Poliovirus type 1

Poliovirus, the most widely studied of all human pathogenic viruses,
was prevalent in water and wastewater. Summarized in Tables 17 and 18,
at 24°C, the LRV of MS2 was 0.6239 logs lower than poliovirus type 1. At
4°C, the LRV of MS2 was 0.2555 logs lower than poliovirus type 1. The data
are displayed in Tables 19 and 20. The LRVs of poliovirus and MS2, at 24°C
and 4°C, were statistically significant.

The LRV of poliovirus was

significantly higher, at both temperatures, when compared to the LRV of
MS2.

This can possibly be attributed to the protein coat of poliovirus,

which consists of 16 proteins, of which 25% alter their charge at a pH less
then 7.0. Specifically, cysteine becomes negatively charged (SH —• S-),
histadine becomes neutral (N+ —>N), and arginine and lysine become less
positive (NH3+ —»• Nhb). Previous studies indicate that transformation of
charge is imperative in the depletion of repulsive electrostatic forces,
which may increase aggregation (Pearson et al., 1964).
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Since the

removal of poliovirus type 1 is higher than MS2 at both temperatures, MS2
is a g o o d indicator of the removal of poliovirus using the CoMag ™
process at the bench.
When the removals of poliovirus type 1 at 24° and 4°C were
statistically analyzed, the p value was 0.026.

This low p value (<0.05)

indicated that there was a statically significant difference in the removal
of poliovirus, at the two different temperatures.

The reduction in the LRV,

at 4°C, as compared to 24°C, may be attributed to a decreased rate of
Brownian motion, which is directly proportional to temperature.

Rotavirus strain Wa

At 24°C, the LRV of rotavirus strain Wa was 0.5726 logs higher than
the removal of MS2. At 4°C, the LRV of rotavirus strain Wa was 0.6272 logs
higher then the removal of MS2. Statistical analysis indicates that there is
a significant difference in the LRV of MS2, at 24°C and 4°C, when
compared to the LRV of rotavirus. Because rotavirus strain Wa is removed
at a greater level than MS2 at the bench, MS2 would be an adequate
surrogate for the removal of rotavirus strain Wa using the bench scale
model of the CoMag™ process.
There was no statistically significant difference in the LRV of rotavirus
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at the two different temperatures, therefore the adsorption and removal
of rotavirus is probably not dependant on temperature.

Wastewater

contains many organic compounds and interaction of the particles within
a wastewater matrix is vastly complex. High concentrations of flocculants
and coagulants are added to wastewater during the CoMag™ process to
bind the organic compounds which compete with viruses for attachment
to magnetite. The flocculants and coagulants also increase the positive
charge on magnetite and viral adsorption is enhanced.

The isoelectric

point of rotavirus strain Wa is lower than the isoelectric point of poliovirus type
1. Therefore rotavirus strain Wa is more strongly electronegative in the pH
range of the bench scale CoMag™ process than poliovirus.

The

attachment of rotavirus strain Wa to the positively charged magnetite by
attractive van der Waals forces may be stronger than the attachment of
poliovirus type 1 making the temperature of the matrix insignificant. The
data are summarized in Tables 21 through 24.

Adenovirus type 2

Adenoviruses are of medium size (90-100 nm), and are the largest
non-enveloped virus. The virion contains a penton fiber^ or spike, that aids
in attachment to the host cell.

At 24°C, the LRV of MS2 was 0.6597 logs
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lower then the removal of adenovirus type 2. At 4°C, the LRV of MS2 was
0.5756 logs lower then adenovirus type 2. Statistical analysis indicates that
there is a significant difference in the LRV of MS2 when compared to the
LRV of adenovirus, at 24°C and 4°C. Adenovirus type 2 is removed at a
greater level then MS2 at the bench under the test conditions employed
for this research. Therefore, MS2 would likely be a sufficient surrogate for
the removal of adenovirus type 2 using the bench scale model of the
CoMag™ process. Statistical analysis also demonstrated that there is no
difference in the removal of adenovirus type 2 at 24°C and 4°C.

The

adsorption and removal of adenovirus type 2 does not appear to be
temperature dependent. Poliovirus type 1 has an isoelectric point that is
much higher than adenovirus type 2.

This may result in a stronger

electronegative force than poliovirus type 1 in the pH range of the bench
scale CoMag™ process.

Like rotavirus strain Wa, the attachment of

adenovirus type 2 to the positively charged magnetite by attractive van
der Waals forces may be stronger than the attachment of poliovirus type
1 making the temperature of the matrix insignificant.
summarized in Tables 25 through 28.

117

The data are

CoMqg™ Pilot Plant

Human enteric viruses cannot be added to wastewater that is
released into the environment because of the high expense of viral
propagation and their pathogenicity to humans. The titers achieved from
the propagation of most enteric viruses are too low for practical use in a
100 gpm pilot plant. Therefore, a virus which is inexpensive to propagate
and is non-pathogenic to humans was used as a model or surrogate. In
previous viral removal studies, MS2 has been utilized as a surrogate for
poliovirus, rotavirus and adenovirus.

MS2 has similar morphological

features, susceptibility to disinfection and survivability in the environment
as compared to some enteric viruses.
The average LRV for the removal of MS2 at 24°C, using the bench
scale model, was 0.8163 logs higher than the pilot plant.

Statistical

analysis demonstrated a significant difference exists in the removal of MS2,
using the bench scale model versus the pilot plant. The data is
summarized in Tables 31 and 32. The removal of MS2 using the bench
scale model is not an adequate representation of the removal of MS2 at
the pilot plant because the bench scale model yielded a significantly
higher LRV.
The data for the CoMag™ pilot plant resulted in no statistically
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significant difference in the removal of MS2, between trails. This result
suggests that the removal of MS2 at the pilot plant for the time period
tested is robust because the variability in the pilot plant stream does not
have a significant effect on the removal of MS2.
The significant difference between the LRVs of MS2 at the CoMag™
pilot plant scale verses the bench scale model can probably be attributed to
the different target pH ranges for each scale. The target pH for the pilot
scale CoMag™ process was 5.5 to 6.1 and the target pH for the bench scale
was narrower at 6.0 +/- 0.1.

Since the isoelectric point of MS2 is 3.9, its viral

surface is more electopositively charged at a pH of 6.0, which was the
targeted pH for the bench scale model. Therefore a higher LRV would be
expected when testing at the bench.
Another factor which may have contributed to the difference of the
LRVs determined for the bench scale model verses the pilot plant process is
the sampling method. At the bench, a single sample was pulled from each
beaker and immediately assayed. Alternatively, sampling for the pilot scale
plant was performed continuously. More specifically, a sample was pulled
every 10 minutes over a period of three hours and assayed after a minimum
hold time of 12 hours. The CoMag™ process removes particles, including
viruses, through adsorption and aggregation. Since the adsorption of
viruses to magnetite is reversible, extended transport and holding times for
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the

samples

could

result in separation

of

the

virus

particles. A

consequence of this would be an increased viral titer resulting in a lower
LRV.
Although evidence supports that MS2 may be a g o o d indicator of
viral removal, these data suggest that it does not serve as an adequate
surrogate for poliovirus type 1, rotavirus strain Wa and adenovirus type 2
when using the CoMag™ process.

The removal differences could be

possibly due to inherent variability in sewage samples.

Several factors

potentially influenced the reduced LRV of MS2 at the pilot plant including
the physiological state of the microorganism, the degree of aggregation,
and the wastewater quality.
More specifically, the reduced removal of MS2 at the pilot plant
may have been due to inadequate mixing throughout the pilot plant
process.

In the bench scale model, the total working volume of

secondary effluent was relatively small, 1000 mL, and mixing was highly
controlled.

At the pilot plant, the tanks had the capacity to mix

thousands of gallons of water. The presence of d e a d zones in the tank,
areas where MS2 did not c o m e into contact with the a d d e d chemicals,
may have contributed to the reduced LRV. Furthermore, the spiked MS2
may have b e c o m e encapsulated in cell debris, aggregated, or adhered
to solid particles, which would have rendered it incapable of adhering to
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the a d d e d magnetite, flocculent or coagulant. The physical properties
such as total suspended solids and turbidity were not assessed in the
secondary effluent used for the bench scale or pilot plant studies.
Therefore, the solids content may have contributed to the variation in the
removal of MS2. This is supported by the fact that the removal of MS2
differed at the bench scale verses the pilot scale process.
In addition, some of the difference in the LRVs of the viruses may be
attributed to the enumeration assays, which were specific for each virus.
MS2 utilizes a bacterial host while poliovirus types 1, rotavirus strain Wa and
adenovirus type 2 require a continuous mammalian cell line. Continuous
cell lines are more fastidious than bacteria and their growth media is
complex and differs for each cell line used for these experiments. They
are also more susceptible to cations, which are present in the CoMag™
processes.

Cations may competitively adhere to the mammalian cells

used to enumerate each virus. This would decrease the amount of virus
able to infect the cell monolayer resulting in an artificially low viral titer.
Viral aggregation may also result in an erroneously low viral titer.

Future Experiments

Several municipal and industrial wastewater treatment facilities are
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advancing from utilizing exclusively primary and biological treatment, to
tertiary treatment, to achieve higher contaminant removal levels now
required by more recent environmental regulations (USEPA, 2006)(USEPA,
2007). The CoMag™ process may be an effective tertiary treatment
process, acting as a method to achieve the more stringent wastewater
discharge permits.

Past research indicates that the CoMag™ process is

capable of reducing phosphorus levels to 0.01 mg/L, arsenic by 93%, total
suspended solids by 98.6%, and biochemical oxygen demand by 63%, in
secondary effluent (Cambridge Water Technology, 2007). Due to the
ability of the CoMag™ process to achieve high levels of particulate
removal and a > 2 LRV of MS2, as determined from the research
presented here, it has the potential to greatly improve wastewater and
drinking water treatment. Use of the CoMag™ process is beneficial
because it is inexpensive, time efficient, and has a compact footprint.
Additionally, less waste product is produced because the bound
magnetite creates a compact sludge and the magnetite that is not
bound is recycled reducing the high cost of sludge disposal.
Despite these advantages, testing the CoMag™ process in the field
would be challenging for several reasons. Firstly, the large volume of water
commonly treated in a wastewater plant would make it difficult to collect
a homogenous sample. Secondly, viruses that are pathogenic to humans
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can not be seeded in a functioning wastewater plant because of the risk
of

infecting

the

public when

discharged

into the

environment.

Furthermore, many environmental factors could not be controlled for such
as heavy metals, water flow (GPM), and temperature.
In both the bench scale and pilot plant studies several variables
were controlled for such as the volume of flocculant, coagulant, and
magnetite, the pH and the settling time in order to minimize variation due
to environmental factors.

In addition, all bench scale experiments were

conducted with a single sample of secondary effluent wastewater.

To

assess the impact of these variables on the resultant LRVs, future research
should include bench scale studies conducted with wastewater samples
collected from several different days and composite samples (where a
sample is gathered every hour for 24 hours and combined). Furthermore,
samples of dilute wastewater, such as when rain events occur, or
concentrated wastewater, as during drought events, should also be
assessed.
Infectious enteric viruses are isolated from raw sewage and
wastewater effluent in greater numbers during the winter months (Fong
and Lipp, 2005).

Furthermore, the efficiency of wastewater treatment

plants decreases during the winter months (Olsen et al., 2005). This creates
an increased potential for the release of enteric viruses into the
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environment.

Further research of the CoMag™ process may include

evaluating seasonal effects on MS2 removal. This may provide an
indication that the CoMag™ process could successfully reduce the
quantity of enteric viruses released into the environment during the winter
months.
A further application of the CoMag™ process could include use as
pretreatment for disinfection methods such as chlorination and ozonation,
which could possibly reduce disinfectant usage and the subsequent
production DBPs.
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APPENDIX A

BUFFERS AND REAGENTS

1% Magnesium Chloride Solution
Dissolve 1 g of MgCl2'6H20 (Fisher) into 99 mLs of distilled water.

IQOx Streptomycin Sulfate/ Ampicillin Antibiotic Solution
A d d 0.15 g of both antibiotics (Sigma) to 100 mLs of distilled water.

1x Phosphate Buffered Saline Solution (PBS)
Dissolve 9.785 g of phosphate buffered saline powder (Sigma) into 1 L of
distilled water. pH to 7.0 and autoclave at 121°C, 15 psi for 15 minutes.
Store at room temperature.

0.1% Crystal Violet Stain
Dissolve 0.1 g Crystal violet into 99 mLs of distilled water.

5M Hydrochloric Acid
A d d 56.9 mLs distilled water into a volumetric flask and bring up to 100 mLs
with HCL. Store at room temperature.

2M Sodium Hydroxide Solution
Dissolve 80 g NaOH pellets (Fisher) with 1 L of distilled water in a plastic
container. Store at room temperature.

10% Formalin Fixative in Normal Saline
Dissolve 8.5 g NaCI (Sigma) into 900 mLs distilled water, a d d 100 mLs of a
37% Fomaldehyde solution. Store at room temperature.
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Trypsin Solution

Add 0.1 g of trypsin (Gibco) to 10 mL of distilled water. Filter sterilize
through a 0.22 um syringe filter and refrigerate until use.
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APPENDIX B

MEDIA

I X Agar Overlay for MS2 Plaque Assay
Dissolve 15 g powdered T-soy broth, 2.5 g NaCI, 5 g Yeast extract, 0.075 g
CaCl2-2H20 and 7.5 g Bacto agar in 1 L distilled water. Boil to dissolve while
mixing then dispense 5 mL portions into test tubes using a Cornwall syringe.
Cap and autoclave test tubes at 121°C, 15 psi for 15 minutes. Store at
room temperature, and melt when needed by autoclaving at 121°C, 15
psi for 5 minutes.

Cell Culture Media for the Propagation of BGMK. MA-104 and Caco-2
Cells
4.7 g Eagles MEM (Sigma)
7.4 g Leibowitz L-15 (Sigma)
4.24 g HEPES (Fisher)
0.292 g L-glutamine (Sigma)
0.75 g Sodium bicarbonate (Sigma)
10 mL Nonessential amino acids (Gibco)
Dissolve components in 1 L distilled water, pH solution to 7.2-7.4, filter
sterilize, refrigerate until use.

10% MEM for MA-104 and Caco-2 Cells
5 mL Antibiotic/Antimycotic (Gibco)
45 mL Fetal Bovine Serum (JRH Biosciences)
450 mL of prepared cell culture media

5% MEM for BGMK Cells
5 mL Antibiotic/Antimycotic (Gibco)
22.5 mLs Fetal Bovine Serum (JRH Biosciences)
450 mL of prepared cell culture media
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2% MEM Maintence Media for BGMK. MA-104 and Caco-2 Cells
5 mL Antibiotic/Antimycotic (Gibco)
9 mL Fetal Bovine Serum (JRH Biosciences)
450 mL of prepared cell culture media

2XMEM
4.7 g Eagles MEM (Sigma)
7.4 g Leibowitz L-15 (Sigma)
4.24 g HEPES (Fisher)
0.292 g L-glutamine (Sigma)
0.75 g Sodium bicarbonate (Sigma)
10 mL Nonessential amino acids (Gibco)
5 mL Antibiotic/Antimycotic (Gibco)
1 mL Kanamycin (Gibco)
Dissolve components in 500 mL distilled water, pH solution to 7.2-7.4, filter
sterilize, refrigerate until use.

Medium 199
2.437 g Ml99 (Sigma)
0.075 g L-glutamine
1.325 g Hepes
0.175 g Sodium Bicarbonate
0.025 g Magnesium Chloride
Dissolve components in 115 mL distilled water, filter sterilize 0.22 Dm,
refrigerate until use.

M l 99 Overlay
79 mL Ml99 (Sigma)
3 mL Neutral Red (Sigma)
3 mL Antibiotic/Antimycotic (Gibco)
Place in 37°C water bath.

Trvptic Sov Broth for E. coli HS (pFamp)R Propagation
Dissolve 30 g powdered T-soy broth into 1 L distilled water, stir and heat
until dissolved. A d d 5 mL/1 L of 1% MgCl2-6H20 solution, and autoclave at
121°C, 15 psi for 15 minutes. After cooling a d d 10 mL/1 L of lOOx
Streptomycin/Ampicillin solution. Refrigerate till use at 4°C.
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